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CHAPTER 1




Chorea-Acanthocytosis (ChAc) (MIM 200150) is a rare autosomal recessive neurodegenerative disorder and 
member of a family of neurological disorders broadly known as neuroacanthocytosis (NA) syndromes1–3. 
NA involves neurological abnormalities coupled with the presence of abnormally spiked red blood 
cells (acanthocytes) in the peripheral blood circulation4. NA syndromes are broadly classified into two 
categories; the “core” NA syndromes and NA with lipoprotein disorders5. The “core” NA group consists of 
ChAc, McLeod syndrome (MLS), Huntington’s disease-like 2 (HDL-2) and pantothenate kinase associated 
neurodegeneration (PKAN); all of which display degeneration of basal ganglia and acanthocytosis5.
ChAc is characterized by progressive adult onset involuntary movements, behavioral and cognitive 
changes, oral dystonia and occasional seizures5–7. Increased creatine kinase levels and a 7-50% 
acanthocytosis in blood circulation are common features of ChAc8. Causative mutations for the onset of 
ChAc are mapped on the Vacuolar Protein Sorting 13A (VPS13A) gene2,8. In most patients, these mutations 
lead to reduction or absence of detectable protein levels in red blood cells10 and hence, Western blotting 
for VPS13A is used as a diagnostic tool in clinical setups4,10,11.
The main cause of red blood cell abnormalities and neurodegeneration in ChAc is largely unknown. In this 
chapter, we will describe a general background of VPS13 family proteins with emphasis on VPS13A. Domain 
architecture, subcellular localizations and functions of VPS13A will be discussed in the context of various 
ChAc model organisms.
The human VPS13 family proteins
The human VPS13 family consists of four ubiquitously expressed proteins (VPS13A, VPS13B, VPS13C and 
VPS13D) that share similarity with yeast Vps1312. Mutations in all human VPS13 genes are associated with the 
onset of neurological and developmental disorders. VPS13A, VPS13B, VPS13C and VPS13D are linked to the 
onsets of ChAc, Cohen syndrome, Parkinson’s disease and septic shock mortality respectively2,13–15.
The VP13A gene spans 73 exons and is located on chromosome 9q21. There are two splicing variants of 
VPS13A (variant 1a and variant 1b). Variant 1a consists of exons 1-68 and 70-73 whereas variant 1b contains 
only exons 1-6912. Mutations in ChAc patients can be found distributed randomly throughout the VPS13A 
gene and so far there are no potential hotspots identified4.
VPS13B is mutated in patients with Cohen syndrome13. Cohen syndrome is a rare autosomal recessive 
disorder characterized by obesity, motor clumsiness, microcephaly, mental retardation, neutropenia, 
facial, oral and ocular abnormalities16–18. VPS13B is located on chromosome 8q22 and widely expressed 
in a variety of human tissues and unlike VPS13A, its expression in adult brain is marginally low13,19. VPS13B is 
required to maintain Golgi integrity and proper protein glycosylation20,21. Although it was initially predicted 
to contain 10 transmembrane domains13, subcellular fractionation study shows that VPS13B is a peripheral 
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membrane protein localized at the Golgi where it interacts with Rab6 to regulate neurite outgrowth with a 
mechanism that remains to be determined20,22.
VPS13C is more similar to VPS13A compared to other VPS13 family proteins12. VPS13C is located on 
chromosome 15q22 where truncating mutations and polymorphisms are causally linked to Parkinson’s 
disease14,23–25. In addition, mutations and single polynucleotide polymorphisms (SNPs) of VPS13C are 
associated with the risk of type 2 diabetes26–29. VPS13C is localized at the mitochondrial membrane and its 
absence aggravates mitochondrial fragmentation and clearance14.
VPS13D is a ubiquitin binding protein that regulates mitochondrial size and clearance both in Drosophila 
and human cultured cells30. Furthermore, a VPS13D gene variant is associated with increased septic 
shock mortality and overproduction of interleukin-6 (IL-6) in patients’ plasma and cultured cells31. 
Recent molecular autopsy analysis identified VPS13D gene mutation as one of the genes linked to early 
embryonic mortality15.
All of the human VPS13 family proteins share conserved N- and C-terminal domains12. Nonetheless, the 
diversity of diseases associated with different human VPS13 family proteins predict that each protein may 
function in different cellular pathways. Indeed, not all human VPS13 family proteins have similar subcellular 
localization patterns. VPS13B is localized to the Golgi complex while VPS13C is localized to mitochondria 
and lipid droplets (LDs)14,20,22,32. VPS13D, on the other hand, colocalizes with the lysosomal protein, 
LAMP130.  The biggest issues to be solved in VPS13A research are to define the localization of the protein in 
mammalian cells33 and to identify functional domains of the VPS13A protein.
Domains of VPS13A
Sequence alignment studies identify multiple domains of VPS13A.  The known domains of VPS13A include 
Chorein, two phenylalanines in an acidic tract (FFAT), short root transcription factor-binding domain (SHR-
BD), aberrant pollen transcription 1 (APT1), ATG-C terminal domain (ATG-C) and pleckstrin homology (PH) 
domain (Figure 1)12,34,35.
Figure 1. Schematic representations of VPS13A and ATG2. Known domains of both proteins are labelled and similar domains are 
color-coded. FFAT (two phenylalanines in acidic tract), SHR-BD (short root transcription factor-binding domain), APT1 (aberrant 
pollen transcription 1), ATG-C (ATG-C terminal domain) and PH (pleckstrin homology), ATG2-CAD (cysteine-alanine-aspartic acid 
triad). CLR (C-terminal localization region)34,35,37–39.
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The Chorein domain is an evolutionarily conserved domain with an unknown function12. The FFAT is a short 
stretch of amino acids commonly present in lipid transfer proteins with properties of building membrane 
contact sites with ER34. The APT1 domain was first identified in maize APT1 protein. APT1 colocalizes with 
a Golgi marker protein in tobacco pollen tubes and mutations in APT1 protein lead to defective pollen 
tube germination and transmission36. In vitro, Vps13 APT1 fragments bind specifically to PtdIns3p35. In the 
primary structure of VPS13A, the APT1 domain is located between SHR-BD and ATG-C domains35,37.
SHR-BD is a highly conserved domain that was previously known as domain of unknown function 1162 
(DUF1162)35. SHR-BD is present in vacuolar protein sorting (At5g24740) of A. thaliana. At5g24740 is also 
known as SHRUBBY and mutation in this gene leads to an aberrant root growth in Arabidopsis40. The 
SHR-BD fragment of Vps13 binds to a variety of phosphoinositides as well as to lysophosphatidic acid 
and phosphatidic acid35. Interestingly, the SHR-BD-APT1 fragment binds specifically to PtdIns3p unlike the 
SHR-BD alone, indicating that APT1 determines the specificity of lipid binding35. VPS13 also contains a PH 
domain and two ATG-C domains that are conserved in both yeast and human35,37,41,42.
A PH domain is composed of approximately 100 amino acids43 and is considered as one of the most 
common domains in the human proteome. PH domain containing proteins are known for their affinities 
to phosphoinositides; specifically to those with a pair of adjacent phosphate groups such as (PtdIns(4,5)
P2 and (PtdIns(3,4,5)P344.
Additionally, VPS13A has two ATG-C domains that show homology with the C-terminal region of ATG2A35. 
There is a 25% identity between the C-terminal regions of VPS13A (aa 2939-3025) and ATG2A (aa 1830-
1916)(Figure 1)39. ATG2 proteins have a membrane binding ability and are essential for autophagy and LD 
distribution39,45. Similarly, VPS13A is also required to maintain proper  autophagic flux 42.
Cellular functions of VPS13A
Most of our current understanding about the cellular functions of Vps13 is derived from studies in 
yeast35,46–54. Vps13 was first identified in a genetic screen for mutants displaying impaired delivery of 
carboxypeptidase Y (CPY) to the vacuole55. Carboxypeptidase Y is a vacuolar protease synthesized in the 
endoplasmic reticulum (ER) as pro-CPY. Pro-CPY is transported to the Golgi complex where glycosylation 
occurs and subsequently delivered to the vacuole where modification to the active form takes place56–58. 
Mutants that fail to transport CPY to the vacuolar compartment secrete pro-CPY to the periplasm and 
ultimately to the extracellular medium55. By screening for secretion defects, together with morphological 
examinations, 41 Vps mutant strains were identified. These mutants are grouped into six classes based on 
their vacuolar morphology 55,59,60. The different classes of Vps mutants and the description of their vacuolar 
morphology is summarized in table 1.
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Table 1. Classification of Vps mutants based on their vacuolar morphology. All Vps mutants secrete CPY at various degrees59. 
Green circles (Vacuoles), small blue circles (fragmented vacuole like structures), orange circles (pre-vacuolar or class E compartment).




Normal vacuolar morphology with 1-3 large 
vacuoles per cell. 
B Vps5, Vps17,Vps39,Vps41
Vps43
Large number (20-40) of small and 
fragmented vacuolar like compartments. 
C Vps11, Vps16,Vps18,Vps33 Severe defect of vacuole assembly. These 
mutants barely show vacuoles, but instead 
accumulate small fragmented vesicles. 
D Vps3, Vps6,Vps9,Vps15
Vps19, Vps21, Vps34,Vps45 
One large vacuole in the parent cell, which 
fails to be acidified and to segregate to 




Possess a different population of vesicles 
(prevacoular endosome like compartment) 
that contain proteins from both late Golgi 
and vacuole. 
F Vps1, Vps26 Large central vacuole surrounded by 
small fragments without any observable 
segregation defects. 
As a member of class-A Vps mutants, Vps13 mutants possess morphologically normal vacuoles59. Further 
characterization revealed that Vps13 is a peripheral membrane protein involved in the transport of 
membrane bound proteins between the trans-Golgi network (TGN) and pre-vacuolar compartment 
(PVC)46,61 or from endosome to vacuole 62. In vps13 mutant cells, there is an increased secretion of insulin 
and pro-CPY46,63. In control cells pro-CPY is actively sorted from late Golgi to vacuole by the sorting 
receptor Vps1064. In Vps13 mutant strains however, Vps10 is mislocalized and rapidly degraded which 
accounts for an apparent extracellular secretion of pro-CPY46. Severe impairment in the production of 
viable spores is also an apparent phenotype of  Vps13 mutants46.
At the earliest phase of sporulation, Vps13 is diffusely distributed throughout the cytoplasm. Whereas later 
in meiosis, it is localized at the prospore membrane48. Compared to wild type strains, Vps13 mutants have 
a few very small prospores that often fail to encapsulate nuclei47. 
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The cellular functions of VPS13 proteins are intricately broad. Studies in several model organisms revealed 
that VPS13A plays an array of conserved roles to maintain protein homeostasis, phosphoinositide 
metabolism, actin cytoskeleton, membrane contact sites and LD homeostasis. 
Knock-out of one of the six Dictyostelium VPS13 genes (VPS13F) delays intracellular destruction 
of phagocytic cargo attributed to failure in sensing bacterial folate without affecting phagosome 
maturation65. Similarly, Tetrahymena VPS13A (TtVPS13A) decorates the phagosome membrane and is 
required for efficient clearance of phagocytic cargo66. In cultured insect cells, Vps13 depletion delays 
endocytic processing67. Another Dictyostelium VPS13 (TipC), was identified in a screen for mutations 
affecting tip formation68, similar to a phenotype that is observed in autophagy mutants69. tipc-/- cells 
accumulate ubiquitinated protein aggregates accompanied by a decreased number of GFP-LC3 and 
GFP-ATG18 puncta. In mammalian cells, depletion of VPS13A raises the number of GFP-LC3 puncta but 
decreases liberation of free GFP indicative for a slow autophagic flux42. 
Both endocytic and autophagic degradation pathways are highly regulated by phosphoinositides70–72. 
Interestingly, synthetic genetic screens revealed that Vps13 mutants show similar sets of genetic 
interactions with Vps30 and Vps3873,74. Vps30 and Vps38 are the components of yeast complex I and 
complex II phosphatidylinositol 3-phosphate kinase (PI3K) complexes, respectively75,76. A plausible 
importance of Vps13 in phosphoinositide metabolism is further established as Vps13 directly binds to an 
array of phosphoinositides35,50. In addition, lipids -such as phosphatidic acid (PA), phosphatidylinositol 
4,5-bisphosphate (PtdIns(4,5)P2 and phosphatidylinositol 4-phosphate (PtdIns4p) are reduced at the 
prospore membrane of Vps13 mutants48. Phosphoinositides regulate a multiplicity of cellular processes 
including actin polymerization and their mis-regulation is linked to a variety of human diseases71,77,78. Of 
importance, impaired actin polymerization is apparent in ChAc patient cells, VPS13A depleted cultured 
cells and Vps13 mutant yeast cells. In different organisms, VPS13A forms a complex with actin35,79. 
Vps13 is localized at multiple membrane contact sites (MCS)49,51,54. MCSs regulate lipid distribution and 
maintain proper lipid gradients across membranes of different organelles80,81. The type and abundance of 
lipid species determines the subcellular localization of MCS proteins82. A number of proteins involved in 
MCSs are identified through bioinformatics, imaging, biochemical and synthetic biology screens83–87. ER 
occupies the largest intracellular space in eukaryotic cells and is essential for the biosynthesis of proteins 
and lipids and the ER regulates cellular calcium homeostasis. It is therefore not surprising that most 
organelles communicate with the ER81,82,88–95. Organelle communication is not limited to the ER and it is 
now clear that MCSs are established between LDs and mitochondria96, peroxisomes and mitochondria97,98, 
lysosomes and peroxisomes99, LDs and endosomes100, nucleus and vacuoles101and mitochondria and 
vacuoles86,87. 
Vps13 is recruited to ER-Mitochondrial Encounter Structure (ERMES), vacuole and mitochondria patch 
(vCLAMP) and NVJ (nuclear vacuole junction) depending on metabolic growth conditions49,54. ERMES 
mutants are synthetically lethal when combined with Vps13 loss of function49,54. When harboring a 
dominant point mutation (Vps13-D716H), Vps13 is able to restore growth defects of ERMES mutants 
suggesting that Vps13 and ERMES are functionally redundant49,51,54. The mammalian ERMES counterpart 
has yet to be  identified  and the role of VPS13A in organelle communication is unknown. 
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AIM AND OUTLINE OF THE THESIS
The overall aim of our research was to uncover the cellular functions of VPS13A in health and disease. The 
biggest hurdles to study the biology of VPS13A were the absence of reliable genetic model systems and 
limited biochemical and labelling tools. This is mainly attributed to the absence of antibodies that would 
detect endogenous VPS13A protein in immunolabelling experiments and partly because of the inherently 
big size of the protein which in turn makes cloning and overexpression difficult. Indeed, Vps13 is the fifth 
largest protein in the yeast proteome49. We initially characterized a Drosophila model of ChAc with an 
aim to investigate phenotypic consequences of VPS13A-loss of function at the organismal level. We next 
aimed to identify the localization and interaction partners of VPS13A in cultured human cell lines. Through 
combined applications molecular biology, biochemistry and cellular imaging, we uncovered previously 
unknown functions of VPS13A in membrane contacts and LD homeostasis. 
Chapter 2: Drosophila Vps13 is required for protein homeostasis in the brain.
Reports about Vps13 function are mainly derived from studies in unicellular eukaryotes such as 
Saccharomyces cerevisiae and Tetrahymena thermophile. The availability of multicellular models to study 
ChAc is limited and there is an obvious demand to generate and validate genetic ChAc models. Although 
VPS13A mutant mouse models that recapitulate some of the ChAc phenotype were generated102, it 
later became clear that the phenotypes were not merely caused by VPS13A loss of function but rather 
dependent on genetic backgrounds103. In this chapter, we aimed to characterize an isogenic Vps13 
mutant Drosophila line and showed that Vps13 deficient flies have motor impairments, shorter lifespan, 
neurodegeneration and accumulation of ubiquitinated protein aggregates. Some of these phenotypes 
were reverted by ubiquitous expression of human VPS13A in Vps13 deficient lines.
Chapter 3: Drosophila Vps13 mutants show overgrowth of larval neuromuscular junctions.
Impaired synaptic communication and plasticity have been previously implicated in many 
neurodegenerative diseases104–106 . The neuromuscular junction (NMJ) is a specialized type of synapse 
that regulates muscle movement by controlling output of neuronal signals107. Cytoskeletal integrity of the 
NMJ not only determines synaptic architecture but also the quality of neuronal impulses107–110.  Although, 
VPS13A depletion leads to mis-stabilized actin cytoskeleton111–113 and abnormal bleb formation at neurite 
terminals of cultured cells114, it is unclear whether defective neuro-synaptic architecture contributes to 
neurodegeneration in ChAc patients or the Drosophila model. In this chapter, we investigated and the 
NMJ anatomy of Vps13 mutants that were validated in chapter 2. Body wall muscles of Vps13 mutants were 
equally developed as their wild type counterparts. Nonetheless, Vps13 mutant larvae were highly mobile. 
Our data also indicate that Vps13 loss of function is associated with a large increase in number of boutons 
that are smaller in size compared to wild type controls. 
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Chapter 4: Human VPS13A is associated with multiple organelles and required for lipid 
droplet homeostasis
In chapter 2, we described that Drosophila Vps13 co-fractionates with endosomal proteins. However, the 
subcellular localization of mammalian VPS13A and interaction partners were unresolved for a long time. In 
this chapter, we provide evidence that VPS13A is localized at the ER-mitochondria interface and directly 
binds to the ER resident protein, VAP-A, through a specific motif. We also show that the VPS13 C-terminal 
part acts as a mitochondrial localization signal. When cellular lipid is surplus, VPS13A shifts from its reticular 
arrangement to LDs where it halts LD mobility. Moreover, we find that, upon VPS13A loss of function, 
LDs accumulate in both cultured cells and Drosophila brain. We also discuss that improper organelle 
communication and LD handling could contribute to the onset and progression of ChAc. 
Chapter 5: Summarizing discussion 
Our research highlights a conserved function of VPS13A to control proper protein homeostasis, neuronal 
growth, organelle communication and LD dynamics. Initially reported as a class A Vps family in yeast, 
Vps13 later emerged as a protein with multiplicity of cellular functions ranging from intracellular transport, 
prospore formation, mitochondrial clearance and MCSs. In this chapter, we summarize and discuss 
the available literature in the VPS13 field and propose a model in which VPS13A is not limited to a single 
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ABSTRACT
Chorea-Acanthocytosis (ChAc, MIM 200150) is a rare, neurodegenerative disorder characterized by 
progressive loss of locomotor and cognitive function. It is caused by loss of function mutations in the 
Vacuolar Protein Sorting 13A (VPS13A) gene, which is conserved from yeast to human. The consequences 
of VPS13A dysfunction in the nervous system are still largely unspecified. In order to study the 
consequences of VPS13A protein dysfunction in the ageing central nervous system, we characterized a 
Drosophila melanogaster Vps13 mutant line. The Drosophila Vps13 gene encoded a protein of similar size 
as human VPS13A. Our data suggest that Vps13 is a peripheral membrane protein located to endosomal 
membranes and enriched in the fly head. Vps13 mutant flies showed a shortened life span and age 
associated neurodegeneration. Vps13 mutant flies were sensitive to proteotoxic stress and accumulated 
ubiquitylated proteins. Levels of Ref(2)P, the Drosophila orthologue of p62, were increased and protein 
aggregates accumulated in the central nervous system. Overexpression of the human VPS13A protein 
in the mutant flies partly rescued apparent phenotypes. This suggests a functional conservation of 
human VPS13A and Drosophila Vps13. Our results demonstrate that Vps13 is essential to maintain protein 
homeostasis in the larval and adult Drosophila brain. Drosophila Vps13 mutants are suitable to investigate 
the function of Vps13 in the brain, to identify genetic enhancers and suppressors and to screen for 
potential therapeutic targets for ChAc.
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INTRODUCTION
Chorea-Acanthocytosis (ChAc) is a rare neurodegenerative disorder characterized by chorea, orofacial 
dyskinesia and psychiatric symptoms including tics (reviewed in 1,2). In addition to the neurological 
symptoms, spiky red blood cells (acanthocytes) are often observed. ChAc is a recessively inherited 
disease caused by mutations in the VPS13A gene, hereafter called HsVPS13A 3,4. These mutations mostly 
lead to absence or reduced levels of the HsVPS13A (or also called chorein) protein5. Symptoms manifest on 
average at the age of 321. The pathophysiology of ChAc is largely unknown and it is not clear why HsVPS13A 
loss of function leads to the symptoms presenting in ChAc patients. HsVPS13A is evolutionarily conserved 
and orthologues are present in various organisms such as Mus musculus, Drosophila melanogaster, 
Caenorhabditis elegans, Tetrahymena thermophila, Dyctiostelium discoidenum and Saccharomyces 
cerevisiae 6-8.
HsVPS13A belongs to the VPS13 family of proteins, which in humans consists of four members, VPS13A to D. 
All members have an N-terminal chorein domain of unknown function. Besides HsVPS13A other members 
of this family are also associated with medical conditions. VPS13B mutations cause Cohen syndrome, a 
developmental disorder characterized by mental retardation, microcephaly and facial dysmorphisms9. 
VPS13B has been reported to be a Rab6 effector that controls Golgi integrity10,11. VPS13C mutations have 
recently been described to cause autosomal-recessive early-onset Parkinson’s disease, probably by 
alteration of mitochondrial morphology and function12. The VPS13C protein has also been suggested 
to play a role in adipogenesis13. Additionally, a number of genetic studies have found an association of 
VPS13C with glucose and insulin metabolism14,15, and of VPS13D with altered interleukin 6 production16.
Knowledge about the cellular function of the Vps13 protein family members mainly comes from 
investigations in S. cerevisiae where a single VPS13 gene encodes a peripheral membrane protein17, Vps13, 
which is involved in the trafficking of multiple proteins from the trans-Golgi network to the pre-vacuolar 
compartment17,18. Vps13 is also required for the formation of the prospore membrane by controlling the 
levels of phosphatidylinositol-4-phosphate19. Recently, it has been demonstrated that Vps13 is important 
for mitochondrial integrity and at least some functions of Vps13 are redundant with functions of ERMES, 
a protein complex that tethers the endoplasmic reticulum and the mitochondria 20,21. Although ERMES 
plays an important role in yeast, so far no counterpart has been identified in metazoans. 
In various organisms Vps13 function has been linked to lysosomal degradation pathways. In the ciliate 
Tetrahymena thermophila TtVPS13A is required for phagocytosis7,22 and in Dictyostelium discoideum TipC, 
the HsVPS13A Dictyostelium orthologue, plays a role in autophagic degradation8. A role for HsVPS13A in 
autophagy has also been supported by experiments performed in human epitheloid cervix carcinoma 
cells, where knock down of HsVps13A leads to an impairment of the autophagic flux8. 
Studies to understand a possible function of VPS13A in the brain are limited. Vps13A knockout mice show 
recapitulation of some of the patient’s characteristics such as acanthocytic red blood cells and an altered 
gait at an older age. Additionally, gliosis and TUNEL positive cells are present in the brain of these mice23. 
However, it is reported that the severity and penetrance of neurological phenotypes in mouse models of 
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ChAc are variable or absent depending on the genetic background of the strains24. Therefore, additional 
animal models are required to identify genetic modifiers and to further understand the role of VPS13A in 
an ageing brain. 
To further study the cellular function of VPS13A in an aging, multicellular model organism with a complex 
central nervous system we used Drosophila melanogaster. We established a Drosophila model for ChAc 
which showed a reduced life span, decreased climbing ability and age-associated neurodegeneration. 
Additionally it showed sensitivity to proteotoxic stress and impaired protein homeostasis. The phenotypes 
of Vps13 mutant flies were rescued by overexpression of the Human VPS13A protein, indicating a functional 
conservation of Drosophila Vps13 and HsVPS13A. Drosophila Vps13 mutants will be valuable for further 
detailed studies to investigate the role of VPS13A in brain tissue and to screen for possible therapeutic 
strategies.
RESULTS
Characterization of Drosophila Vps13 mutant flies 
ChAc is caused by mutations in the VPS13A gene 3,4, which lead to absence or reduced levels of HsVPS13A 
protein5. The Drosophila genome encodes for three predicted Vps13 proteins, orthologues to human 
VPS13A, B and D; in this study we focused on the structural orthologue of HsVPS13A, further referred to 
as Vps136. The Exelixis Drosophila fly line Vps13c03628 carries a PiggyBac transposable element in an intronic 
region of the Vps13 gene (Figure 1A)25. Flies heterozygous for this mutation (Vps13-/+) did not show any 
mutant phenotype; homozygous mutants (Vps13-/-) were viable and were investigated further. Analysis 
by qPCR showed lower levels of Vps13 mRNA in homozygous Vps13 mutant flies (Figure 1B). Polyclonal 
antibodies were raised against two different epitopes of the Vps13 protein (Figure 1A). Both antibodies 
recognized a band in extracts from control fly heads (Figure 1C,D), which migrated with the same mobility 
as the human protein in samples derived from HEK293 cells and detected with a HsVPS13A-specific 
antibody (Figure 1F). Vps13 was highly enriched in samples from fly heads compared to samples from 
whole flies (Figure 1E), suggesting that Vps13 is enriched in the Drosophila central nervous system. In 
homozygous Vps13 mutant flies full length Vps13 protein levels were below the detection limit, visualized 
using Western blot analysis using the antibody against the C-terminal domain (Figure 1C). The antibody 
directed against the N-terminal part of the protein, recognized a truncated Vps13 product in extracts 
of homozygous mutants, consistent with the presence of the Piggybac element insertion, indicating 
that the antibodies are specific, that the expression of full length Vps13 is strongly decreased and a 
truncated Vps13 product is present in mutant flies (Figure 1C-E). Exact excision of the PiggyBac element 
in 3 independent lines resulted in recovery of the expression of a full length Vps13 protein in fly heads 
(Figure 1F, Supplementary Figure 2A). The excision lines were used as controls in further studies. These 
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Fig 1. Vps13c03628 encodes for a truncated Vps13 protein.
(A) Schematic representation of the Vps13 gene and the genomic localization, RNA and protein is depicted. The epitopes of the 
polyclonal Vps13 antibodies (Vps13 NT and Vps13 #62) are indicated.(B) Relative levels of Vps13 mRNA in control and Vps13 mutant 
flies were determined by Q-PCR. Mean and SEM (n=2) are plotted. (C) Western blot analysis of Vps13 protein in control and Vps13 
mutant fly heads using the Vps13 #62 antibody. β-Actin was used as a loading control. (D) Western blot analysis of the level of Vps13 
protein in control and Vps13 mutant fly head extracts analyzed with the Vps13 NT antibody. α-tubulin was used as a loading control. 
(E) Lysates of the heads of control flies and whole control flies were analyzed for Vps13 levels. α-tubulin was used as a loading control. 
(F) Lysates of the heads of control flies, Vps13 mutant flies and three excision lines were analyzed for Vps13 levels. Human VPS13A 
was detected in samples of Hek293 cells. Drosophila samples and human samples were run on the same gel, separated by a lane 
containing the molecular weight standards, after transfer of the membrane, the marker lane was split to detect human and Drosophila 
VPS13 separately using species specific antibodies. The marker lane was used to align the blots after antibody detection. α-tubulin 
was used as a loading control.
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Fig 1. Vps13c03628 encodes for a truncated Vps13 protein.
(A) Schematic representation of the Vps13 gene and the genomic localization, RNA and protein is depicted. The epitopes of the 
polyclonal Vps13 antibodies (Vps13 NT and Vps13 #62) are indicated.(B) Relative levels of Vps13 mRNA in control and Vps13 mutant 
flies were determined by Q-PCR. Mean and SEM (n=2) are plotted. (C) Western blot analysis of Vps13 protein in control and Vps13 
mutant fly heads using the Vps13 #62 antibody. β-Actin was used as a loading control. (D) Western blot analysis of the level of Vps13 
protein in control and Vps13 mutant fly head extracts analyzed with the Vps13 NT antibody. α-tubulin was used as a loading control. 
(E) Lysates of the heads of control flies and whole control flies were analyzed for Vps13 levels. α-tubulin was used as a loading control. 
(F) Lysates of the heads of control flies, Vps13 mutant flies and three excision lines were analyzed for Vps13 levels. Human VPS13A 
was detected in samples of Hek293 cells. Drosophila samples and human samples were run on the same gel, separated by a lane 
containing the molecular weight standards, after transfer of the membrane, the marker lane was split to detect human and Drosophila 
VPS13 separately using species specific antibodies. The marker lane was used to align the blots after antibody detection. α-tubulin 
was used as a loading control.
Vps13 co-fractionates with Rab7 and Rab5 
We aimed to determine the subcellular localization of Vps13 in brain tissue; however, the antibodies that 
were generated against Vps13 failed to show a specific staining using immunolabeling. We therefore 
followed a cell fractionation approach to determine the subcellular localization of Vps13. We found that 
Vps13 was mainly, but not exclusively, present in the isolated membrane fraction (Figure 2A). To determine 
whether Vps13 is a peripheral or integral membrane protein, the membranes were treated with a variety 
of buffers to extract proteins as previously described26. High salt buffer could not remove Vps13 from 
the membrane fraction, while high pH and high concentration of urea did (Figure 2B). This shows that 
Vps13 has characteristics similar to a peripheral membrane protein, such as Golgi Matrix protein 130 kDa 
(GM130)26, but different from an integral membrane protein like Epidermal Growth Factor Receptor 
(EGFR), both of them were used as controls in these experiments (Figure 2B). The membrane fraction 
was separated on a sucrose gradient and the distribution of Vps13 was determined in relation to marker 
proteins for various organelles. The distribution of Vps13 was different compared to the distribution of 
markers for Golgi (GM130), lysosomes (Lamp1) and mitochondria (ATP5A) (Figure 2C and E). Vps13 was 
mainly present in fractions 12 to 16 in which also Rab5 and Rab7, Rab-GTPases involved in the regulation of 
endosomal trafficking, were present. Rab5 is mainly present on early endosomes and Rab7 is enriched on 
late endosomes27. To study this further, Rab7 positive membranes from fraction 14 were immuno-isolated 
and Vps13 was shown to be present in these samples (Figure 2D). Furthermore, Rab7, but not Rab5 was 
enriched in membranes immuno-isolated with Vps13 antibodies (Figure 2D). Together, these data suggest 
that Vps13 is a peripheral membrane protein associated with Rab7 positive membranes. 
Vps13 mutant flies have a decreased life span and show age dependent neurodegeneration
After validation of the Drosophila Vps13 mutant and characterizing its subcellular localization, we 
investigated the physiological consequences of impaired Vsp13 function. Characteristics of several 
Drosophila models for neurodegenerative diseases are a decreased life span, impaired locomotor 
function and the presence of brain vacuoles28. As a control an isogenic fly line (w1118) and 3 independent 
precise excision lines were used. Homozygous Vps13 mutant flies showed a decreased life span compared 
to isogenic controls and the excision lines (Figure 3A-C, Supplementary Table 1). 75% of the mutant flies 
died between 16 and 20 days of age while control flies showed a more gradual decline (Figure 3B). Young 
Vps13 mutant flies showed climbing capabilities comparable to controls, however around day 17 the 
climbing ability of Vps13 mutant flies was decreased (Figure 3D, Supplementary movie 1). 
To further investigate neurodegenerative features in Vps13 mutants, brain sections were analyzed by light 
microscopy and an increase in vacuoles was observed in brains of 20 day old flies while they were absent 
in brains from isogenic controls (Figure 3E). Vacuoles in Vps13 mutant flies were (among other regions) 
present in the central complex, known for its function in locomotor control (Figure 3F)29. The impaired 
locomotor function upon ageing, shortened life span and the presence of large vacuoles in the brain of 












































































































































Fig 2. Vps13 co-fractionates with Rab7 and Rab5
(A) Western blot analysis of control fly head samples fractionated into a cytosolic and membrane fraction from postnuclear supernatant 
(PNS). EGFR was used as a membrane marker and GAPDH as a cytosolic marker. (B) Membrane fractions from control fly heads treated 




 pH 11 or 6 M urea were centrifuged to separate the soluble and insoluble (membrane containing) fractions. The 
level of Vps13 was determined in these fractions. Markers for peripheral membrane proteins (GM130), integral membrane proteins 
(EGFR) and the cytosolic proteins (GAPDH) were used. The “Vps13 lysate” lane contains a lysate derived from Vps13 homozygous 
mutant fly heads, as expected no Vps13 is detected, demonstrating the specificity of the antibody against Vps13. (C) Membranes from 
control fly heads were fractionated on a sucrose gradient. Western blot analysis was performed to analyze the distribution of Vps13 in 
relation to markers associated with membranes of various organelles: Rab7 (late endosomes), Rab5 (early endosomes), GM130 (golgi), 
Lamp1 (lysosomes) and ATP5A (mitochondria). (D) Immunoisolation of membranes from fraction 14 of the sucrose gradient using 
Vps13 NT, Rab7 and Rab5 antibodies. (E) Quantification of the sucrose gradient fractionation of Fig 2C.




























































































































Fig 3. Vps13 mutant flies show a decreased life span, age dependent impairment of locomotor function and neurodegeneration.
(A) Life span analysis of isogenic control and Vps13 mutant flies. (B) The fraction of dead flies of total flies used,observed within the 
indicated time intervals. (C) Life span curve of Vps13 mutant flies and three excision lines. (D) Climbing behavior was analyzed by 
determining the percentage of isogenic control and Vps13 mutant flies (4 and 17 days old) able to climb 5 cm against gravity within 15 
seconds. Mean and SEM are plotted (n=5). For statistical analysis a two-tailed students T-test was used. P<0.001 is ***. (E) Fly heads (20 
day old) of control and homozygous Vps13 mutant flies were fixed, dehydrated and embedded in epon. Sections, visualizing a cross 
section of the complete brain, were stained with toluidine blue. The scale bar indicates 50 µm.(F) Higher magnification images of the 
boxed area’s in Fig E. The central complex is denoted with a dotted line. The scale bar indicates 25 µm.
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Vps13 mutant flies show impaired protein homeostasis
Since neurodegenerative phenotypes are often linked to impaired protein homeostasis, we investigated 
the viability of Vps13 mutants under proteotoxic stress by using a previously established eclosion assay30. 
The percentage of homozygous survivors was 19.76% of the total amount of eclosing flies at 25oC (Figure 4A), 
which is less than the expected 33.3% according to Mendelian inheritance. This indicates that the viability 
of Vps13 mutants was decreased compared to controls. To induce proteotoxic stress we analyzed the 
eclosion rate at increased temperature. The eclosion rate further decreased in a temperature dependent 
manner, indicating a temperature sensitivity of Vps13 homozygous animals during development (Figure 
4A). As controls, the excision lines were tested and no decreased viability at 29oC was observed (Figure 
4B). Subsequent crosses with the Vps13 allele over two deficiency lines lacking a genomic region including 
the Vps13 gene (Supplementary Figure 2C) also showed a decreased eclosion rate at 29oC (Figure 4C), 
supporting the fact that temperature sensitivity is due to loss of Vps13 function.
To further investigate increased sensitivity to proteotoxic stress, Vps13 mutant flies were fed with 
L-canavanine, an arginine analogue that induces protein misfolding, during development31. Vps13 
homozygous mutants showed an L-canavanine induced decrease in eclosion rate in a concentration 
dependent manner (Figure 4D) indicating a defect in the ability of these flies to maintain protein 
homeostasis. Defects in cellular protein homeostasis are often associated with an accumulation of 
ubiquitylated proteins32. Indeed, extracts derived from Vps13 mutant fly heads contained increased levels 
of ubiquitylated proteins compared to isogenic controls and excision lines (Figure 4E, Supplementary 
Figure 2B). Extracts derived from flies containing the Vps13 allele over a deficiency chromosome gave 
comparable results (Supplementary Figure 2D). Further specification revealed an increase in lysine K48 
ubiquitylated high molecular weight (around 170 kDa) proteins, however no difference was observed in 
K63 ubiquitylated proteins (Figure 4E). Because K48 ubiquitylated proteins are targeted for degradation, 
this accumulation may indicate that Vps13 mutant flies suffer from an impairment in protein homeostasis32. 
Protein aggregation in Drosophila Vps13 mutant central nervous system
Impaired protein homeostasis often leads to the aggregation of proteins, therefore protein aggregation 
was investigated in Vps13 mutants. Larval ventral nerve cords and brains from adult flies were dissected, 
fixed and stained for DAPI to visualize structures containing neuronal cell bodies (DAPI positive) and to 
visualize neuropils (DAPI negative), containing axons and dendrites33-35. The tissues were co-stained for 
Ubiquitin. Mainly neuropils in both larval ventral nerve cords and adult brains of Vps13 mutants showed an 
increased number of ubiquitylated protein puncta compared to control (Figure 5A-E and Supplementary 
Figure 3 and 4). Furthermore, samples from Vps13 mutant fly heads contained more Triton x-100 insoluble 
ubiquitylated proteins compared to controls (Supplementary Figure 3C), indicating an accumulation of 
protein aggregates in Vps13 mutants. Protein aggregation is often accompanied by an accumulation 
of Ref(2)P, the Drosophila orthologue of p6236. Western blot analysis showed an increase in Ref(2)
P in Vps13 mutant fly heads compared to isogenic control and excision line fly heads (Supplementary 
Figure 2B). Extracts derived from fly heads of the Vps13 allele over a deficiency gave comparable results 
(Supplementary Figure 2D). In addition a partial colocalization was observed between Ref(2)P and ubiquitin 
















































































































































































































Fig 4. Impaired Vps13 function leads to defects in protein homeostasis.
(A) Percentage of isogenic control and Vps13 mutant flies that eclosed at increasing temperatures. (B) Percentage of homozygous 
Vps13 mutant flies and excision line flies that eclosed at 29 oC. (C) Percentage of flies of various genotypes that eclosed at 29 oC. 
Two independent deficiency lines (lacking a genomic area containing the Vps13 gene) were crossed with Vps13/ CyO heterozygous 
flies. Eclosion rate of the following genotypes was analyzed: Vps13/+, Df #7535/+, Vps13/Df #7535, Df #7534/+ and Vps13/Df #7534. 
(D) Percentage of Vps13 flies that eclosed at 22 oC on food with increasing concentrations of L-canavanine. (E) Western blot analysis 
of lysates of 1 day old control and Vps13 mutant fly heads. Ubiquitylated proteins, K48 ubiquitylated proteins and K63 ubiquitylated 
proteins were detected. All quantifications show the mean and SEM of at least three independent experiments per condition. For 
statistical analysis a two-tailed students T-test was used in combination with a Welch’s correction if necessary. P<0.05 is *, P<0.01 is ** 
and P<0.001 is ***.
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positive protein aggregates in Vps13 mutant brains mainly in areas containing neuronal cell bodies (Figure 
5E, Supplementary Fig 4). This is consistent with published data showing the accumulation of ref(2)P in 
autophagy mutants and proteostasis mutants mainly in DAPI-positive areas36. These experiments show 
that Vps13 mutant flies accumulate protein aggregates in the central nervous system of larvae and adult 
flies.
Vps13 mutant phenotypes are rescued by overexpression of HsVPS13A
Homozygous Vps13 mutants display various characteristics indicative of neurodegeneration accompanied 
by an impairment in protein homeostasis. To further validate our model and investigate its relevance 
for HsVPS13A function we overexpressed HsVPS13A in the Vps13 mutant background. The sequences of 
Vps13 and HsVPS13A show 29% identity, while the N-terminal chorein domains have an identity of 50% 
(Supplementary Figure 1). Using the UAS-GAL4 system37 HsVPS13A was ubiquitously overexpressed in the 
Drosophila Vps13 mutant background to investigate whether this could rescue the phenotypes observed 
in the Vps13 mutant flies. Fractionation and Western blot analysis, using an antibody against the HsVPS13A 
protein, showed that HsVPS13A was expressed in the transgenic flies and was mainly present in the 
membrane fraction (Figure 6A). Overexpression of HsVPS13A in the Vps13 mutant background increased 
the viability (Figure 6B), reduced the amount of ubiquitylated proteins (Figure 6C-E) and decreased 
the number of ubiquitylated protein puncta in the larval ventral nerve cord (Figure 6D). In addition, 
overexpression of HsVPS13A extended the life span of Vps13 mutant flies (Figure 6F, Supplementary table 
1). These results indicate not only a structural conservation but also a functional conservation between 
the human VPS13A and the Drosophila Vps13 protein for at least a subset of the functions of these proteins.























































































































******Figure 5 continues on the next page.
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Fig 5. Central nervous system of larval and adult Vps13 mutants contain protein aggregates.
(A) Ventral nerve cords of control, Vps13 mutant, Vps13/Df #7534 and Vps13/Df #7535 third instar larvae were stained for ubiquitylated 
proteins and DAPI. The presence of DAPI indicates areas where nuclei of neuronal cell bodies or glial cells are located. DAPI negative 
regions represent areas mainly containing axonal and synaptic structures (33,35). The areas in the grey boxes are shown below as 
higher magnification images. The scale bar indicates 50 µm. (B) Quantification of the number of ubiquitylated protein puncta in the 
ventral nerve cord. (C) Staining of 1 day old adult control brains using DAPI. The grey box denotes the area in the brain where the two 
antennal lobes are located. The presence of DAPI indicates areas where nuclei of neuronal or glial cell bodies are located. The center 
area which is negative for DAPI contains axonsand synaptic structures (34). The scale bar indicates 50 µm. (D) Quantification of the 
number of puncta of ubiquitylated proteins in the antennal lobes derived from 1 day old isogenic controls, Vps13 mutants and excision 
line 3. (E) Staining of brains derived from 1 day old controls, Vps13 mutants and excision line 3 flies for ubiquitylated proteins, Ref(2)p 
and DAPI. The scale bar indicates 20 µm Arrows indicate colocalization of Ref(2)P and Ubiquitin positive foci. All quantifications show 
the mean and SEM of at least three independent experiments per condition. For statistical analysis a two-tailed students T-test was 
used in combination with a Welch’s correction if necessary. P<0.05 is *, P<0.01 is ** and P<0.001 is ***.
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DISCUSSION
ChAc is a recessively inherited neurodegenerative disorder caused by loss of function mutations in the 
HsVPS13A gene3,4. The study of HsVPS13A function and the pathological mechanisms playing a role in 
ChAc is hampered by the limited availability of multicellular models for ChAc. Although Vps13A knock-out 
ChAc mouse models were generated, they possess variable or no abnormalities in brain tissue depending 
on the genetic background24. This underscores the complexity of studying VPS13A in the central nervous 
system and suggests the presence of genetic factors playing a role in the phenotype induced by impaired 
function of VPS13A in the brain. The goal of this study was to use Drosophila melanogaster to establish a 
relatively simple multicellular model for ChAc and study the consequences of Vps13 dysfunction in the 
ageing central nervous system.
We established a Drosophila melanogaster model for ChAc by using Vps13 mutant flies which express 
a truncated Vps13 protein. ChAc has been shown to be caused by loss-of-function mutations, most of 
them leading to total absence of protein5. In addition, alteration of the most C-terminal region of the 
main protein isoform, leading to the presence of a truncated protein, have also been found5,(Velayos-
Baeza et al, unpublished results). Although a detailed phenotypic study of ChAc patients comparing 
consequences of no protein or a truncated protein present, has not been performed, it can be 
concluded that the main features of the disease are present in all cases regardless the presence of a 
truncated protein or the absence of VPS13A protein. The presented Drosophila model may be of use 
for future studies to investigate effects of various specific mutations in the VPS13A gene and how this 
affects protein homeostasis, neurodegeneration and life span. The Vps13 mutant flies show progressive 
neurodegenerative phenotypes such as a shortened life span, impaired locomotor function and the 
presence of vacuoles in brain tissue at older age28. These phenotypes are accompanied by defects in 
protein homeostasis and by accumulation of protein aggregates in the central nervous system. Many 
neurodegenerative diseases are characterized by defects in protein homeostasis and the accumulation of 
protein aggregates in the brain38. It will be of interest to investigate protein homeostasis and the presence 
of p62 positive protein aggregates in ChAc mouse models or in post-mortem tissue of affected ChAc 
individuals.
Our results demonstrate that Drosophila Vps13 is a peripheral membrane protein associated with Rab7 
positive membranes. Rab7 positive late endosomes are involved in lysosomal protein degradation 
pathways such as autophagy and phagocytosis39, suggesting a role of Drosophila Vps13 in the lysosomal 
degradation pathway. This is consistent with findings that knock down of HsVPS13A is associated 
with impaired autophagic degradation in HeLa cells8. In addition, an accumulation of Ref(2)P and 
colocalization with Ubiquitin positive dots was also observed in Drosophila autophagy mutants36, further 
suggesting a role for Vps13 in autophagy. It should be stressed however that Ref(2)P accumulation and 
colocalization with Ubiquitin also occurs when proteosomal degradation is impaired. Future research is 
therefore required to determine whether impaired autophagy or impaired proteosomal degradation (or 
both) lay at the base for the disturbed protein homeostasis in Vps13 mutants. Furthermore, a study in 
Tetrahymena thermophila suggests a potential role for VPS13 in phagocytosis7. Together, these studies 
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Fig 6. Overexpression of HsVps13A rescues phenotypes of Vps13 mutants.
(A) Samples from fly heads of Actin-GAL4 / + (as a control) and Actin-GAL4 / UAS-HsVps13A (HsVps13A expressing) flies were 
separated into a membrane and cytosol fraction and analyzed by Western blot for HsVps13A levels. EGFR and GAPDH used as controls 
for membrane and cytosolic proteins, respectively. (B) Eclosion rate of Vps13 mutant flies a Actin-GAL4/+ (control) or Actin-GAL4/
UAS-HsVp13A (HsVps13A expressing) background at 25 oC. (C) Ubiquitylated proteins from samples of 1 day old fly head extracts of 
Vps13/CyO ; Actin-GAL4/+ (as a control), Vps13/ Vps13 ; Actin-GAL4/+ (representing homozygous mutants) and Vps13/ Vps13 ; Actin-
GAL4/UAS-HsVps13A (representing homozygous mutants expressing human VPS13A). (D) Representative picture of ubiquitylated 
protein staining of the third instar larval ventral nerve cord of Vps13/CyO ; Actin-GAL4/+ (as a control), Vps13/ Vps13 ; Actin-GAL4/+ 
and Vps13/ Vps13 ; Actin-GAL4/UAS-HsVps13A. Arrows indicate accumulations of ubiquitylated positive structures. The scale bar 
indicates 50 µm and 12,5 µm in the enlargement. (E) Quantification of the number of puncta in third instar larval ventral nerve cord 
of the experiment presented in figure 6D. (F) Life span curve of Vps13/ Vps13 ; Actin-GAL4/+ and Vps13/ Vps13 ; Actin-GAL4/UAS-
HsVps13A. All quantifications show the mean and SEM of at least three independent experiments per condition. For statistical analysis 
a two-tailed students T-test was used in combination with a Welch’s correction if necessary. P<0.05 is *, P<0.01 is ** and P<0.001 is ***.
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show that a number of lysosomal degradation pathways may potentially be affected by VPS13 dysfunction, 
and together this could contribute to the impaired protein homeostasis in Vps13 mutants. In an ageing 
organism damaged proteins may accumulate and cause the observed neurodegenerative phenotype40. 
Future research is required to show whether Drosophila and human VPS13A play a role in a single or in 
multiple lysosomal degradation pathways and whether in the nervous system VPS13 is linked to membrane 
contact sites, as was demonstrated for VPS13 in yeast 20,21.
The Drosophila Vps13 mutant phenotype was partly rescued by human VPS13A, demonstrating at least 
a degree of functional conservation between flies and human. The availability of our characterized 
Drosophila model will enable future genetic screens to find modifiers of ChAc and will enable screens for 
chemical compounds that rescue one or multiple pertinent phenotype(s) of neurodegeneration. 
MATERIALS AND METHODS
Fly stocks and genetics
Fly stocks were maintained and experiments were done at 25 oC on standard agar food unless otherwise 
indicated. The Vps13{PB}c03628 stock was acquired from the Exelixis stock centre 25 and isogenized to 
the w1118 stock. The generation of the isogenic controls was performed as previously described41. In short, 
The isogenic fly lines that serve as a control were generated by backcrossing the Vps13 mutant line for 
6 generations with the control stock (w1118). Backcrossing the mutant line for 6 generations is required to 
remove background mutations and isogenized control stocks are being generated and used as controls 
in all experiments. The following stocks were acquired from the Bloomington Stock Centre: w1118; CyO, 
P{Tub-PBac\T}2/wgSp-1 (8285), Df(2R)Exel6053 (7535), Df(2R)Exel6052 (7534), Actin-GAL4/Tm6B (3954).
The Vps13{PB}c03628 excision lines were created by crossing the Vps13{PB}c03628 stock with the 
PiggyBac transposase overexpressing fly line (Bloomington stockcenter; #8285) to remove the Piggybac 
insertion. The acquired “Hopout” chromosomes of these excision lines were balanced over CyO and 
three independent offspring lines balanced over CyO were established. They are referred to as excision 
lines 1 to 3.
Generation of HsVPS13A expression flies
The full-length cDNA of the human VPS13A gene, variant 1A, corresponding to positions 252 to 9907 of 
GeneBank NM_033305 (but containing synonymous SNPs rs17423984 (A5583G, Thr1861Thr) and rs3737289 
(A9069G, Gly3023Gly), was available after combination of several fragments amplified by RT-PCR (6) and 
cloning into pcDNA4-TO-mycHis (Invitrogen). To obtain a plasmid for expression of HsVPS13A in D. 
melanogaster, the above insert was transferred to vector pUAST37. The plasmid was sent to Bestgene for 
embryo injection and generation of the transgenic flies.
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Physiological assays
Crosses for the life span assays were performed at 25 oC and offspring were selected 24 hours after the 
start of eclosion. 10 to 20 flies per tube were housed at 25 oC and put into fresh vials every 3 or 4 days. The 
incidence of dead flies was counted at least every 4 days. Life spans were repeated at least three times.
The climbing assay was performed with at least 5 vials with 10 to 15 flies each. The flies were tapped to the 
bottom and the amount of flies that reached 5 cm within 15 seconds was noted as climbers and flies under 
the 5 cm mark were scored as non-climbers. Experiments were repeated three times.
Crosses to determine the eclosion rate were performed with 10 female and 5 male flies. The flies were 
allowed to mate for 48 hours on Bloomington food at the indicated temperatures. The amount of offspring 
of the indicated genotypes was determined 5 days after eclosion of the first progeny. L-Canavanine 
(Sigma), was mixed with the food at the indicated final concentrations. Sensitivity to L-Canavanine was 
determined as previously described (30). In short: heterozygous Vps13 males and females (flies carrying a 
chromosome containing the Vps13 mutation over a balancer chromosome (Vps13/CyO)) were allowed to 
mate and the number of homozygous Vps13 mutant progeny was determined and given as percentage 
of the total progeny (sum of heterozygous (Vps13/Cyo) plus homozygous progeny (Vps13/Vps13)). Under 
control conditions the percentage homozygous Vps13 eclosing progeny is 33 % (because the CyO/CyO 
genotype causes lethality). To determine the eclosion rate of combinations of different alleles, the alleles 
under investigation (Vps13, w1118 or one of the deficiency lines) were balanced over CyO and mated with 
each other (e.g. Vps13/CyO x Df #7535/CyO). . Based on Mendelian laws, the percentage of non-CyO 
progeny flies from these crosses is around 33%. When the viability of the non-CyO flies is compromised, 
the percentage non-CyO eclosing flies is lower than the expected 33% of the total eclosing flies. For all 
eclosion experiments more than 100 eclosed flies were scored per condition. Due to toxicity of the Actin-
GAL4 driver in the Vps13 background, all rescue experiments using human VPS13A were performed at 25 
oC. 
Western blot analysis
Flies were flash frozen in liquid nitrogen and heads were separated from bodies by using a vortexer. 30 
µl freshly prepared Laemmli buffer (2% SDS, 5% 2-mercaptoethanol, 10% glycerol, 0.004% bromophenol 
blue, 0.0625 M Tris HCl pH 6.8) was added per 10 heads and the samples were sonicated three times for 5 
seconds on ice. 5% 2-mercapthoethanol (Sigma) was added and the samples were subsequently boiled for 
5 minutes. Samples were run on 12% polyacrylamide gels and transferred onto nitrocellulose membranes. 
For Vps13 detection the samples were prepared using 2x Laemmli buffer without 2-mercaptoethanol 
containing 0,8 M urea and 50 mM DTT. The samples were run on a 6% polyacrylamide gel and blotted 
overnight using transfer buffer containing 10% methanol. Membranes were incubated in 5% milk in PBS 
0,1% Tween-20 and subsequently stained using the primary antibody in PBS 0.1% Tween-20 over night at 
4 oC. Staining with secondary antibodies (1:4000, GE Healthcare) was done at room temperature in PBS 
0.1% Tween-20. Signal on membranes was visualized using ECL or super-ECL solution (Thermo Scientific) 
in the dark room, the GeneGnome (Westburg) or the ChemiDoc Touch (BioRad).
38 CHAPTER 2
The following antibodies were used for Western blot analysis: beta-actin (1:2000, Cell Signalling, #3700), 
alpha-tubulin (1:4000, Sigma, T5168), ubiquitylated proteins (1:1000, FK2, Enzo life sciences, BML-
PW8810-0500), K48-ubiquitinated proteins (1:1000, Cell signalling, #8081), K68-ubiquitinated proteins 
(1:1000, Cell signaling, #5621), Ref(2)p (42), HsVPS13A (1:1000, Sigma, HPA021662), EGFR (1:1000, Santa 
Cruz Biotechnology, sc-03-G), GAPDH (1:1000, Novus biologicals, NB100-56875), GM130 (1:2000, Abcam, 
ab30637), Rab5 (1:1000, Abcam, ab31261), Rab7 (1:1000, (43), ATP5A (1:5000, Mitoscience via Abcam, MS507) 
and Lamp1 (1:1000, Abcam, ab25630).
Generation of Drosophila Vps13 antibodies
The Vps13 #62 antibody was made by immunizing rabbits with a synthetic peptide containing the amino 
acids 3299 to 3314 of Vps13 (Eurogentec). A dilution of 1:1000 was used for Western blot experiments.
For the Vps13 NT antibody Vps13 cDNA corresponding to amino acids 576-976 was cloned in pET28a 
(Novagen) to generate a His-Tag fusion protein that was expressed and purified with Ni-NTA resin 
(Qiagen) following manufacturer’s instructions. The resulting recombinant protein was used to immunize 
rabbits. This antibody was used in a 1:1000 dilution for Western blot analysis.
TX-100 detergent fractionation
Separation of the Triton X-100 insoluble and soluble fractions of fly heads was performed as described 
in44. In short, fly heads of 7 day old flies were separated from the bodies by freezing in liquid nitrogen and 
subsequent vortexing. The heads were kept on ice and homogenized with a pellet pestle in 1% Triton 
X-100 in PBS containing protease inhibitors. The sample was centrifuged at 4 oC at 20800 g for 10 minutes. 
The supernatant was removed and the samples were washed in 1% Triton X-100 in PBS containing protease 
inhibitors. After a second centrifugation step the supernatant was removed, 5% Laemmli buffer was added 
and the sample was sonicated on ice. 5% beta-mercapthoethanol was added and the sample was boiled 
for 10 minutes. 
Cytosol vs Membrane fractionation and membrane extraction
A slightly modified protocol45 was used. Approximately 800 fly heads were resuspended in 800 µl 
homogenization buffer HB (50mM Tris HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, Protease inhibitor) and 
mechanically shredded using a pellet pestle motor (Kontes). The nuclei and intact cells were pelleted 
by centrifugation 5 min at 800 g, and the resulting postnuclear supernatant (PNS) was applied to 
ultracentrifugation at 100,000 g for 1 h using a TLA 100.3 rotor to generate the cytosol (C) and the 
membrane fraction (M). To analyze the association of Vps13 with membranes, the membrane fraction 
was treated with HB, 1 M KCl, 0.2 M sodium carbonate (pH 11), or 6 M urea for 45 min on ice, and then 
separated into a supernatant (Soluble) or a pellet (Insoluble) fraction by centrifugation at 4°C, 100,000 
g for 1 h. Laemmli sample buffer was added to the insoluble and soluble fractions and the samples were 
processed for Western blot analysis.
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Subcellular fractionation and immunoisolation
A protocol based on Silvis et al.46 was used. In short: For subcellular fractionation around 1000 fly heads 
were resuspended in 1 ml of homogenization buffer HB (50mM Tris HCl pH 7,5, 150mM NaCl, 1mM EDTA, 
Protease inhibitor, 0.25 M sucrose). The fly heads were homogenized by 20 strokes of a Potter-Elvehjem 
PTFE pestle and centrifuged at 800 g for 5 min, the pellet was discarded and the supernatant (post nuclear 
supernatant, PNS) was collected. The fly heads PNS was then pipeted onto a sucrose gradient containing 
5%, 17.5%, 30%, 42.5%, 55% (w/v) in HB, the volume was 2 ml per concentration, and the gradient was spun 
at 4 °C at 274 000 g for 4 h using a swinging bucket SW41 rotor in a Sorvall Discovery 90se. Fractions of 0.5 
ml were harvested top to bottom from the gradient and transferred into 1.5 ml microcentrifuge tubes. The 
proteins present in each fraction were precipitated and concentrated using TCA, resuspendend in 75 µl of 
sample buffer, processed for Western blot analysis as described before and analyzed by Western blot. All 
the procedures were performed on ice.
To perform the immunoisolation, a Vps13-enriched fraction containing vesicles positive for markers 
of the early and late endosomal populations was obtained as described above. The Vps13 enriched 
fraction (30% sucrose) was collected (approximately 1 ml). Rabbit anti-Rab7, anti-Rab5, anti Vps13 NT, or 
a nonspecific rabbit IgG was added to the Vps13 enriched fraction and incubated overnight at 4°C with 
rotation. In addition, 30 µl A/G plus agarose beads per condition were washed with 1% BSA/HB three 
times and incubated with 1 ml 1% BSA/HB overnight at 4°C. The following day the beads were recovered 
and resuspended in 30 µl of HB per condition. 30 µl of the blocked and washed beads were then added 
and incubated with each condition for 3 h at 4°C with rotation. The bead–antibody–organelle complexes 
were collected and washed five times with HB. Laemmli sample buffer was added to the immunoisolated 
complexes, and samples were analyzed using Western blot analysis to detect the indicatedproteins.
Q-PCR
RNA was extracted from whole flies (RNeasy purification kit) and transcribed into cDNA (M-MLV, Invitrogen). 
Q-PCR was done using Sybergreen (Biorad) and a Biorad i-cycler. The primers were directed to a sequence 
downstream of the PiggyBac insertion. RP49 mRNA levels were used for normalization. The following 
primers were used for Vps13 mRNA: For – AGACGTGCCTGGGTCTAT and Rev – AAGGCTCGTGAGAGGTAC; 
and for RP49 mRNA: For – GCACCAAGCACTTCATCC and Rev – CGATCTCGCCGCAGTAAA.
Immunofluorescence
Adult and L3 larval brains were dissected in PBS and directly put on ice. The brains were fixed for 20 minutes 
in 3.7% formaldehyde and subsequently washed 3 times 10 minutes in PBS 0.1% Triton X-100, followed by 
an optional 1 hour blocking at room temperature in 10% normal goat serum in PBS 0.1% Triton X-100. 
Primary antibodies: ubiquitylated proteins (1:200, FK2, Enzo life sciences, BML-PW8810-0500) and Ref(2)




Flies were sedated using CO
2
, the proboscis was removed and the flies were decapitated. The heads 
were immediately transferred into fixative at 4°C containing 2% Glutaraldehyde, 0.2% picric acid and 4% 
paraformaldehyde in 0.1 M Cacodylate buffer. The fly heads were fixed at 4°C on a rotator for at least 48 
hrs followed by three wash steps with Cacodylate buffer. Next, the heads were transferred to postfix (1% 
osmium tetroxide and 1,5% potassiumferrocyanide in 0.1 M Cacodylate buffer) for 2hrs at 4°C and washed 
with ddH
2
O, dehydrated using an ethanol series and embedded in Epon. Thick sections were produced 
using a Leica EM UC7 Ultramicrotome, sections were transferred to glass slides, stained using Toluidine 
blue and imaged with an Olympus BX50 light microscope.
Quantifications and statistical analysis
Quantification of images obtained by immunohistochemistry (ubiquitylated proteins and Ref(2)p 
accumulations) of the central nervous system were blindly scored. In ImageJ a region of 250 by 250 pixels 
in the center of the brain was selected to exclude the background fluorescence at the edges of the brains. 
Subsequently the puncta were counted using the “find maxima” function.
The statistical significance of the data was calculated using the Student’s t-test (2-tailed and where 
appropriate with welches correction). Plotted values show the average of at least 3 independent 
experiments and error bars show the standard error of the mean. P-values below 0,05 were considered 
significant. In the figures P≤0,05 is indicated by a *, P≤0,01 by ** and P≤0,001 by ***.
Significance of the life span analyses was calculated with Graphpad prism5 using a Log-rank (Mantel-Cox) 
Test and a Gehan-Breslow-Wilcoxon Test. Graphs and life span curves were made using Graphpad prism5.
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Sup Fig 1. Alignment of Vps13 and HsVps13A.



































































































































Sup Fig 2. Western analysis of Vps13, excision lines and deficiency lines.
(A) Western blot analysis of Vps13 protein level in isogenic control, Vps13 mutant and excision line fly heads using the Vps13 #62 
antibody. Tubulin was used as a loading control. (B) Western blot analysis of ubiquitylated proteins and Ref(2)p in control, Vps13 mutant 
and excision line fly heads. Tubulin was used as a loading control. (C) Western blot analysis of Vps13 protein in Vps13/+, Vps13, Vps13/
Df #7534 and Vps13/Df #7535 fly heads using the Vps13 #62 antibody. Tubulin was used as a loading control. (D) Western blot analysis 
of ubiquitylated proteins and R=ef(2)p in Vps13/+, Vps13, Vps13/Df #7534 and Vps13/Df #7535 fly heads. Tubulin was used as a loading 
control.
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Sup Fig 3. Accumulation of puncta of ubiquitylated protein in the larval ventral nerve cord.
(A) Ventral nerve cords of control and Vps13 mutant third instar larvae were stained for ubiquitylated proteins. The areas in the grey 
boxes are shown below in higher magnification. Quantification of the number of puncta in the ventral nerve cord is given. The scale 
bar indicates 50 µm and 12.5 µm in the enlargement. (B) Quantification of the number of puncta present in a 250 by 250 pixel section 
of larval ventral nerve cord as depicted in 5A. (C) Triton x-100 fractionation of samples from control and Vps13 mutant fly heads 
analyzed for the levels of Triton x-100 insoluble ubiquitylated proteins. The quantification shows the mean and SEM of at least five 
larval ventral nerve cord stainings per condition. For statistical analysis a two-tailed students T-test was used in combination with a 

















DAPI Ref(2)pUbiquitin Ubiquitin / Ref(2)p / DAPI
Sup Fig 4. Accumulation of ubiquitylated protein puncta in the adult eye lobe.
Stainings of the eye lobes of 1 day old adult control, Vps13 mutant and excision line 3 stained for ubiquitylated proteins, Ref(2)p and 
DAPI. The higher magnification pictures are of the areas in the grey boxes. Arrows indicate colocalization of Ref(2)P and Ubiquitin 
positive foci . The scale bar in the overview picture indicates 50 µm and the scale bar in the zoom in indicates 20 µm. 
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Supplemental table 1
Figure Genotype # of ﬂies Median life span P value M-C test P value G-B-W test
3 Control 142 37 days
Vps13 159 20 days < 0,0001 < 0,0001
3 Vps13 164 18 days
Excision line #1 414 54 days < 0,0001 < 0,0001
Excision line #2 141 53 days < 0,0001 < 0,0001
Excision line #3 259 53 days < 0,0001 < 0,0001
6 Vps13 69 5 days
Vps13 + HsVps13A 71 6 days < 0,0001 0,0016
Sup Table 1. Details of the life span experiments presented.
Depicted per figure are the fly lines used, the number of flies used for the experiment, the median life span, the Mantel-Cox test (M-C 
test) and Gehan-Breslow-Wilcoxon test (G-B-W test).
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ABSTRACT
Chorea-Acanthocytosis is a rare neurodegenerative disorder caused by mutations in the VPS13A gene 
which lead to a severe reduction or absence of the VPS13A protein. How loss of this protein affects neuronal 
functioning is not known. In this chapter we use a Drosophila Vps13 mutant to study the consequences of 
Vps13 loss of function on neuronal development and plasticity in the larvae. Vps13 homozygous mutant 
larvae showed increased crawling speed, while their muscle size was not increased compared to wild type 
controls. This phenotype is associated with an overgrowth phenotype of neuromuscular junctions and the 
appearance of type 2 boutons. These characteristics point to an aberrant regulation of neuronal plasticity. 
The active zone marker, Bruchpilot, did not show increased staining intensity in Vps13 mutants compared 
to controls. However, the boutons of Vps13 mutant larval neuromuscular junctions contained more 
intense staining for the glutamate receptor, GluR2A. In conclusion, Vps13 mutants possess characteristics 
of a hyperkinetic phenotype which is associated with overgrowth of the larval NMJ.
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INTRODUCTION
The neurodegenerative disorder Chorea-Acanthocytosis (ChAc) is characterized by chorea, orofacial 
dyskinesias, seizures and psychiatric symptoms1. It is caused by loss of function mutations in the VPS13A 
gene, which lead to reduced expression of the VPS13A protein2-4. The underlying mechanism of how 
VPS13A loss of function leads to neuronal dysfunction and neurodegeneration is not known.
Neurons differentiated from ChAc patient derived induced pluripotent stem (IPS) cells show increased 
spontaneous synaptic activity5. This increase is rescued when the cells are treated with an actin cytoskeleton 
stabilizing drug, suggesting that the increased activity is due to actin polymerization defects5. Additionally 
the cells also show increased neurite outgrowth 5. In VPS13A knock down PC12 cells the neurite outgrowth 
after NGF stimulation is not altered, however the neurites display an abnormal morphology6. These results 
suggest a role for VPS13A in the regulation of neuronal activity and neurite formation.
Synaptic plasticity is the process in which neuronal connections change under changing conditions7. 
These conditions include learning and memory, growth, development and changing environmental 
conditions7. Under these conditions the synaptic connections with other neurons or muscles needs to 
be adjusted according to the altered circumstances. As an example, during learning and memory, new 
connections between neurons are created while  specific existing connections are strengthened7. 
An established system in Drosophila to study synaptic plasticity is the larval neuromuscular junction 
(NMJ). NMJs are the structures where the termini of neurons innervate the muscles leading to muscle 
contraction and larval movement8. During the three larval stages in Drosophila development the larva 
grows several magnitudes in size. Accordingly, the muscles grow as well and in order to innervate these 
muscles the amount of neuronal synapses, called boutons, need to increase as well9.
To understand the function of VPS13A we established, characterized and validated a Drosophila line 
harboring a mutation in the Drosophila ortholog of the human VPS13A gene, further referred to as Vps13. 
To investigate the effects of Vps13 dysfunction on neuronal function we studied larval NMJs. We found 
that Vps13 mutant larvae showed faster crawling behavior which did not coincide with an increase in 
muscle size. The NMJ of Vps13 mutant third instar larvae showed more boutons and the presence of 
type 2 boutons. The immunoreactivity of the glutamate receptor in the NMJ was increased suggesting 
the presence of more glutamate receptors. These results suggest that Vps13 is important in maintaining 
proper neuronal plasticity and postsynaptic glutamate receptor levels.
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RESULTS
Vps13 mutant third instar larvae show increased basal larval locomotor activity 
We previously showed that Vps13 loss of function resulted in a locomotor impairment in adult flies10. In 
order to investigate the locomotor behavior in larvae, we used a previously established assay to monitor 
larval mobility11. The Vps13 mutant larvae showed a higher basal larval locomotor activity compared to 
control larvae (Figure 1A and B). 
Larval motility is mainly regulated by the proper coordination of neuronal innervation and muscle 
contraction12. In order to find the underlying mechanism for the locomotor phenotype in Vps13 mutant 
larvae we studied the larval NMJ. The Drosophila larva is compartmentalized in a number of segments 
with repeating patterns of muscles and neurons innervating these muscles (Figure 2A)13.
Vps13 mutant larvae show NMJ overgrowth
Vps13 mutant larvae showed faster crawling behavior which is not associated with the presence of larger 
muscles. 
The increase in basal larval locomotor function therefore may be caused by changes in neuronal activity. 
Increased neuronal activity is associated with an increase in the amount of NMJ boutons and thereby an 
increased larval crawling speed8. Environmental conditions like rearing temperature and nutrition also 
influence the bouton number of the NMJs and the basal larval locomotor activity8, 14.
The neurons of the larvae were visualized by staining with an antibody against HRP, which binds a neuronal 
antigen and stains presynaptic terminals, and by staining for Fas2, a neuronal marker for Drosophila NMJs. 
Fas2 is a protein involved in the growth and stabilization of neurons9. Fas2 mutants do not develop synapses 
at the NMJ and are not viable9. The Vps13 mutant NMJs of muscle 6/7 and 4 showed an increased amount 
























Fig 1. Vps13 mutant third instar larvae show increased basal larval locomotor activity.
(A) The crawling trajectory of a control and Vps13 mutant larva within 1 minute on an agar plate. (B) Quantification of the crawling 
distance of control and Vps13 mutant larvae within 1 minute. Mean and SEM of the crawling distance from at least 8 larvae is indicated.
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of boutons compared to NMJs of control (Figure 3A and B, Figure 4A and B). Because the Vps13 Drosophila 
mutants were created by a Piggybac transposable element, a line in which this transposable element is 
precisely excised can serve as an additional control10. Indeed, NMJs of the excision line contained equal 
amounts of boutons compared to wild type NMJs (Figure 3). Most boutons present in control NMJs are 















































































Fig 2. The muscle size of Vps13 mutant third instar larvae is comparable to control.
(A) Staining of the third instar larval NMJ for neurons using an anti-HRP antibody (green) and for muscles using Rhodamine-Phalloidin 
(polymerized Actin, red). The insert shows a higher magnification of the NMJ of muscles 6 and 7, of segment 2 of the larva. (B) 
Schematic representation of the muscles of the third instar larva. The muscle number is indicated for each muscle. (C) Staining of the 
muscles in segment A2 of control and Vps13 mutant. (C) Quantification of the size of muscle 4, 6 and 7 of segment A2 as shown in the 
pictures in C. Mean and SEM of the size of at least 8 muscles per condition is shown.
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2 boutons are smaller than type 1 boutons, often present in long strings and are mainly present under 
conditions of NMJ overgrowth15.
Bruchpilot staining intensity in the NMJ of Vps13 mutant larvae is comparable to wild type  
The active zones of the pre-synaptic neuron are the areas where vesicles with neurotransmitters fuse with 
the presynaptic membrane16. The assembly of the active zones is controlled by a protein called Bruchpilot16. 
It is a large cytoskeletal-like protein which oligomerizes and functions as a scaffold for synaptic vesicles to 
bind to and facilitates the release of their content in the synaptic cleft16,17.
The puncta of Bruchpilot present in the boutons are indicative of the active zones present in these 
boutons (Figure 5A). The pattern of Bruchpilot puncta in NMJs of Vps13 mutants was comparable to NMJs 
of control or excision line larvea (Figure 5C). Additionally, the intensity of Bruchpilot staining was not 
changed (Figure 5B). The total level of Bruchpilot in samples from adult heads, enriched in neuronal tissue, 
was also not changed (Figure 5D). These results indicate that the amount of active zones was not changed 
in Vps13 mutants.
Fig 3. The amount of boutons in the NMJ of muscle 6 and 7 of Vps13 mutants is increased.  
(A)  Staining of the third instar larval NMJ of muscle 6 and 7 in control, Vps13 mutant and an excision line  for HRP (green) and Fas2 (red). 
(B) Quantification of the amount of boutons of control, Vps13 mutant and excision line third instar larvae. Mean and SEM of at least 8 
NMJ’s are plotted. (C) Higher magnification picture of type 2 boutons present in the Vps13 mutants. The arrowhead indicates a type 1 
bouton and the arrows indicate type 2 boutons.
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Glutamate receptor staining intensity is increased in Vps13 mutant larval boutons
The main excitatory neurotransmitter in the Drosophila central nervous system is acetylcholine. The 
Drosophila NMJ, however, uses glutamate as its neurotransmitter, comparably, glutamate is the main 
excitatory neurotransmitter of the human brain7.
Postsynaptic glutamate receptors in the Drosophila NMJ are responsible for detecting the neurotransmitter 
in the synaptic cleft after which the muscle depolarizes18. Changes in the amount of glutamate receptor 
therefore have large impact on the efficiency of neuronal signaling in the Drosophila NMJ. GluR2A and 
GluR2B are the main ionotropic glutamate receptors expressed in the Drosophila larval muscles18. The 
two receptors have a redundant function and knocking out both receptors, -and not only one-, leads to 
embryonic lethality 18. Increased levels of GluR2A causes strengthening of the synaptic transmission and 
NMJ overgrowth 19,20. 
GluR2A is present in the postsynaptic membrane of the muscle of both the controls and Vps13 mutants 
(Figure 6A). However, the GluR2A staining in the Vps13 mutant boutons was more intense compared 
to the boutons of control and excision line third instar larvae (Figure 6A and B).  An increase in GluR2A 
presence in Vps13 mutant postsynaptic densities suggests an increase of glutamate receptor signaling 
and may indicate an increased synaptic communication.
Fig 4. The NMJ of muscle 4 of Vps13 mutants has an increased amount of boutons.
(A) Fas2 (red) and HRP (neurons, green) staining of control, Vps13 mutant and excision line third instar larval NMJs of muscle 4. (B) 
quantification of the amount of boutons at NMJ 4 of control, Vps13 mutant and an excision line. Mean and SEM of at least 9 NMJ’s are 
plotted. (C) Higher magnification picture of the boxed area in Fig 4A. Type 2 boutons are indicated with arrows and type 1 boutons 
with arrowheads.
357 NMJ overgrowth in Vps13 mutants
Fig 5. Bruchpilot staining intensity is not changed in Vps13 mutant larvae.
(A) Staining for Bruchpilot (red) and HRP (green) in the NMJ’s of control, Vps13 mutant and excision line 2 third instar larvae. (B) 
Quantification of the Bruchpilot staining intensity per bouton in control, Vps13 mutant and excision line NMJ. Mean and SEM of at 
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Fig 6. Glutamate receptor staining intensity is increased in the third instar larval NMJ of Vps13 mutants.
(A) NMJ’s of control, Vps13 and excision line third instar larvae stained for HRP (neurons, green) and glutamate receptor 2A (red). (B) 
Quantification of the intensity of GluR2A staining at the boutons of control, Vps13 and excision line NMJ’s. Depicted is the mean and 
SEM of the intensity of at least 70 boutons.
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DISCUSSION
The Vps13 mutants showed an increase in basal larval locomotor activity. This was not correlated with 
an increase in the muscle size but with an increase in the amount of neuronal boutons of the NMJ. In 
contrast to controls the Vps13 mutants also displayed type 2 boutons, which is consistent with previous 
reports demonstrating that type 2 boutons  are associated with faster crawling and NMJ overgrowth 8,15.
The NMJ size is controlled by several genetic and environmental factors, among which is the level of 
activity of the autophagy pathway21. The autophagy pathway is a catabolic pathway which degrades cellular 
constituents like proteins and organelles and can be influenced by both genetic and environmental 
changes. Increased autophagic flux leads to an increased amount of NMJ boutons while defects in 
autophagosome formation leads to a decreased amount of  boutons21. Vps13 dysfunction has been shown 
to lead to impaired autophagic degradation22, therefore we expected Vps13 dysfunction to lead to a 
decrease of NMJ bouton number. However in contrast to this we found an increased amount of boutons 
in Vps13 mutant NMJs. This discrepancy points to a potentially more complex regulation of NMJ size in 
Vps13 mutants than only by the autophagy pathway. 
In a genome wide RNAi screen for genes involved in endocytosis, Vps13 was identified as one of the 
hits. Knock down of Vps13 in S2 cells, a Drosophila cultured cell line, leads to decreased endocytosis23. 
Therefore Drosophila Vps13 may affect the NMJ by its role in the endocytic pathway. Many endosomal 
mutants, like Dynamin, Endophilin and Synaptojanin mutants, lead to the increased development of 
boutons and especially lead to the appearance of many satellite boutons24. Satellite boutons are small 
protrusions emanating  from a primary bouton24. However in  Vps13 mutants no satellite boutons were 
observed. This suggests that although Vps13 knock down impairs endocytosis23, the Vps13 mutant NMJ 
phenotype is clearly distinct from other endocytic mutants. 
Vps13 mutant phenotypes are comparable to phenotypes of Drosophila Spinster mutants. The late 
endosomal protein Spinster plays a role in both endocytic trafficking and in autophagic degradation25,26. 
Spinster mutants have NMJ overgrowth and developmental defects which lead to a severely lowered 
viability just as Vps13 mutants27,28. Interestingly, the overgrowth of the Spinster mutant NMJs can be 
rescued by inhibiting autophagy29. Additionally, the developmental defects of a zebrafish Spinster mutant 
could also be partially rescued by inhibiting autophagy [26]. In line with this we showed that the decreased 
viability of Vps13 mutants could be partially rescued by inhibition of autophagy (Unpublished results). Taken 
all these data together Vps13 mutants have many similarities with Spinster mutants. These similarities may 
be related to a function of Spinster and Vps13  in both endo-lysosomal and autophagosomal degradation.
Increased GluR2A staining intensity was observed at NMJs of Vps13 mutants, which suggests an increase 
in the postsynaptic level of GluR2A. Overexpression of GluR2A leads to higher signal transmission at the 
NMJ and NMJ overgrowth19. Elevated GluR2A levels are also required for NMJ overgrowth and increased 
basal larval locomotor activity under certain conditions like higher rearing temperatures14. A higher level 
of GluR2A could therefore contribute to the NMJ overgrowth in Vps13 mutant condition. This increase in 
NMJ size could subsequently lead to an increase in locomotor activity, consistent with previous reports8.
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Our results point to an effect of Vps13 dysfunction on NMJ development and synaptic plasticity. 
Therefore, it may be interesting to investigate other processes in Drosophila which are influenced by 
synaptic plasticity, like learning and memory. It will also be of interest whether influencing the neuronal 
plasticity, either genetically or pharmacologically, has an effect on Vps13 mutant phenotypes like the 
NMJ overgrowth and larval crawling speed or possibly on viability, life span and neurodegeneration, 
phenotypes associated with Vps13 mutant adults as reported in Vonk et al. 10.
MATERIALS AND METHODS
Fly stocks and genetics
Fly stocks were maintained and experiments were performed at 25 oC on standard agar food. The 
Vps13{PB}c03628 stock was acquired from the Exelixis stock centre [30] and isogenized to the w1118 stock. 
The generation of the isogenic controls was performed as previously described. The excision fly lines 
were established previously by precise excision of the Piggybac element from the Vps13{PB}c03628 flies10.
Larval crawling assay
The larval crawling assay was performed as published previously11. Crosses of the specific genotype were 
done at 25 degrees on Bloomington Nutrifly food. Third instar larvae were put on a petridish containing 
non-nutritive agar and the crawling distance within 1 minute was measured. This was repeated three times 
and the average distance per minute was calculated. 
Western blot analysis
Flies were flash frozen in liquid nitrogen and heads were separated from bodies by using a vortexer. 30 
µl freshly prepared Laemmli buffer (2% SDS, 5% 2-mercaptoethanol, 10% glycerol, 0.004% bromophenol 
blue, 0.0625 M Tris HCl pH 6.8) was added per 10 heads and the samples were sonicated three times for 5 
seconds on ice. 5% 2-mercapthoethanol (Sigma) was added and the samples were subsequently boiled for 
5 minutes. Samples were run on 12% polyacrylamide gels and transferred onto nitrocellulose membranes. 
Membranes were incubated in 5% milk in PBS 0,1% Tween-20 and stained using the primary antibody in 
PBS 0.1% Tween-20 over night at 4 oC. Staining with secondary antibodies (1:4000, GE Healthcare) was 
performed at room temperature in PBS 0.1% Tween-20. Signal on membranes was visualized using ECL or 
super-ECL solution (Thermo Scientific) in the ChemiDoc Touch (BioRad).The following antibodies were 
used for Western blot analysis:, alpha-tubulin (1:4000, Sigma, T5168), NC82 (1:100, Bruchpilot, DSHB).
NMJ dissections, staining and imaging
Size matched third instar larvae were dissected in PBS and fixed in 3.7% formaldehyde except in GLurIIA 
stainings where larvae were fixed in Bouin’s fixative. Larval fillets were permeabilized in 0.1% triton x-100 
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followed by blocking in Bovine Serum Albumin or Normal Goat Serum (Invitrogen). The following primary 
antibodies were used: anti-HRP (Jackson’s immunoresearch), anti BRP, FAS-2 and GluRIIA (DSHB). Z stack 
confocal images of muscle 6 and 7 or muscle 4 were taken on a zeiss 780 microscope. Images were 
maximally projected using Image J and the mean intensity values per bouton were calculated. Bouton 
numbers were counted manually by a person blinded for the experimental conditions.
Quantifications and statistical analysis
The statistical significance of the data was calculated using the Student’s t-test (2-tailed and where 
appropriate with welches correction). Plotted values show the average and error bars show the standard 
error of the mean. P-values below 0,05 were considered significant. In the figures P<0,05 is indicated by a 
*, P≤0,01 by ** and P≤0,001 by ***.
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CHAPTER 4
Human VPS13A is associated with multiple 
organelles and required for lipid droplet 
homeostasis 
Wondwossen M. Yeshaw, Marianne van der Zwaag, Francesco Pinto, Liza Lahaye, 
Anita Faber, Rubén Gómez-Sánchez, Sven van IJzendoorn, Nicola Grzeschik, 
Ody C.M. Sibon.




Human VPS13A is highly conserved among eukaryotes and associated with the autosomal recessive 
neurodegenerative disease Chorea Acanthocytosis (ChAc). The cellular function, localization and 
dynamics of the VPS13A protein are unknown. Here, we show that VPS13A is associated with mitochondria 
and establishes membrane contact sites with the endoplasmic reticulum (ER) by interacting with VAP-A, 
via a FFAT domain, a binding influenced by calcium levels. Upon increased fatty acid uptake, VPS13A 
translocates from mitochondria to newly formed lipid droplets (LDs). Localization of VPS13A to LDs pauses 
their movements whereas loss of VPS13A induces increased LD motility and size. Accordingly, VPS13A 
plays a conserved role in LD homeostasis in Drosophila, as in its absence these organelles accumulate 
in glia cells of the central nervous system, a phenotype associated with neurodegeneration, impaired 
locomotor function and decreased life span. Altogether, our data link VPS13A with multiple organelles and 
its dysfunction induces an alteration in LDs homeostasis. 
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INTRODUCTION
The vertebrate VPS13 protein family consists of four closely related proteins, VPS13A, VPS13B, VPS13C 
and VPS13D 1. The VPS13D gene variants are linked with embryonic lethality, higher IL-6 production and 
septic shock lethality 2,3. Mutations in VPS13B and VPS13C are associated with the onset of neurological 
and developmental disorders 4–8. Mutations in the VPS13A gene are causative for a specific autosomal 
recessive neurological disorder, Chorea Acanthocytosis (ChAc). Most reported VPS13A mutations in ChAc 
patients result in low levels or absence of the protein 9. ChAc patients display gradual onset of hyperkinetic 
movements and cognitive abnormalities. In addition to neuronal loss, the presence of circulating spiky 
red blood cells (acanthocytes) 1,5 implies that the function of VPS13A is not restricted to the brain but also 
to other tissues. In line with this, VPS13A mRNA is ubiquitously expressed in human tissues 1,5. 
Despite their medical relevance, the molecular and cellular function of VPS13 proteins remains largely 
unknown. The limited knowledge is largely derived from studies about yeast Vps13. Vps13 is a peripheral 
membrane protein. It is involved in the transport of membrane bound proteins between the trans-Golgi 
network and prevacuolar compartment (PVC) 10,11 and from endosome to vacuole 12. Vps13 is also required 
for prospore expansion, cytokinesis, mitochondrial integrity, membrane contacts and homotypic fusion. 
Last, the influential role of Vps13 in these processes is postulated to be dependent on the availability of 
phosphatidylinositides 13–19. It is currently unclear whether the four mammalian VPS13 proteins share similar 
functions with yeast Vps13. The cellular localization and function of VPS13A is largely unknown.
The VPS13A gene is located at chromosome 9q21 and encodes a high molecular weight protein of 3174 
amino acids 4,5. In various model systems, loss of VPS13A is associated with diverse phenotypes, such as 
impaired autophagic degradation, defective protein homeostasis 20–22, delayed endocytic and phagocytic 
processing 23,24, actin polymerization defects 25–28 and abnormal calcium homeostasis 29,30. These studies 
indicate that VPS13A plays a role in a multitude of cellular functions and its loss of function is associated 
with a wide range of cellular defects in eukaryotes. Here, to understand the versatile role of VPS13A at 
the molecular level, the subcellular localization, dynamics, binding partners and the role of the domains 
of VPS13A were determined in mammalian cells. Our results demonstrate that VPS13A is a protein with 
unique properties since it is associated to multiple organelles, its localization dynamically shifts upon 
altered levels of fatty acids and VPS13A influences lipid droplet homeostasis. These findings were further 
substantiated in a validated neurodegenerative Drosophila model for ChAc 22 using a large scale scanning 
electron microscopy (nanotomy) approach enabling identification of affected cells in large cross sections 
of the central nervous system. We discuss how these findings can explain neurodegeneration in ChAc. 
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RESULTS
Human VPS13A is a peripheral membrane protein 
To determine the subcellular localization of endogenous human VPS13A, we first separated the membrane 
and cytosolic fractions of HeLa cells by high-speed centrifugation. VPS13A was enriched in the pellet, 
which contained the transmembrane epidermal growth factor receptor (EGFR) and relatively little of 
α-tubulin, a cytosolic marker protein (Figure 1A). To further investigate the membrane association of 
VPS13A, a detergent based subcellular fractionation was performed in HEK293T cells 31. Following digitonin 
treatment and centrifugation, more than 80% of VPS13A, remained in the fraction containing membrane 
associated proteins such as EGFR and the ER integral protein VAP-A, and little VPS13A was detected in the 
cytosolic non-membrane bound and GAPDH containing fraction (Figure 1B and B’). The type of membrane 
association of VPS13A was further investigated by assessing its dissociation from lipid bilayers after 
treatment with different chemical agents. Similar to ATP5A, a peripheral membrane associated protein of 
mitochondria; part of VPS13A was solubilized by alkaline and urea-containing solutions. In contrast, the 
integral membrane protein EGFR remained in the membrane pellet irrespective of the treatment (Figure 
1C and D). Altogether, these analyses revealed that VPS13A is a peripheral membrane-associated protein.
To determine to which intracellular membranes endogenous VPS13A is associated to, we next performed 
subcellular fractionation experiment on a sucrose gradient. This experiment showed that VPS13A was 
predominantly detected in fractions containing VAP-A, Rab7 and ATP5A, which are marker proteins of the 
ER, endosomes and mitochondria respectively (Figure 1E and F).
VPS13A localization to mitochondria is mediated via the C-terminal end
To characterize the subcellular localization of VPS13A in more detail, GFP- and Myc-tagged VPS13A was 
expressed in HEK293T cells. This yielded a high molecular weight band, corresponding to full-length 
tagged VPS13A (Supplementary Figure 1A and B). Under normal growth conditions, VPS13A-GFP showed 
two main subcellular distribution patterns. In approximately 90% of the cells, VSP13A displayed a reticular 
pattern (Figure 2A). In the remaining cells, VPS13A localized to vesicular structures (Figure 2A’). To identify 
these compartments, we co-localized VPS13A with a variety of organelle marker proteins. Although 
not co-localizing with the endosomal and lysosomal marker proteins Rab5, Rab7, LAMP1 and FYCO1 
(Supplementary Figure 1C-F), VPS13A-GFP strongly decorated the circumference of nearly all mitochondria 
stained with mitotracker (Figure 2B and B’, and Supplementary movie 1). The striking VPS13A localization to 
the mitochondrial surface prompted us to determine the VSP13A domain that mediates this localization. 
To do so, we expressed GFP-tagged truncated forms of VPS13A (Figure 2C and Supplementary Figure 2) 
in different cell lines. Whereas most of the constructs were cytosolic, the C-terminal region of VPS13A (aa 
2615-3174) strongly localized to the mitochondria in the cell lines tested (Figure 2D and Supplementary 
Figure 3A-C). The localization of the VSP13A C-terminal domain to the surface of mitochondria was 
identical to the full-length VPS13A localization (Figure 2E). This strongly suggests that the C-terminal 
region of VPS13A is involved in targeting the protein to a close vicinity of the mitochondrial membrane. 
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Figure 1. VPS13A is enriched in membrane fractions and is peripherally associated to membranes.
(A) Light membrane fractions from HeLa cell homogenates were separated by centrifugation in a cytosolic and a membrane fraction. 
Equal amounts of proteins were processed for immunoblotting against VPS13A, EGFR and α-tubulin. (B) Digitonin extraction of 
cytosolic proteins in HEK293T cells. HEK293T cells were treated with digitonin on ice and the cell free fraction containing cytosolic 
proteins was collected after centrifugation. The remaining pellet containing all membranes was lysed in buffer containing NP-40. 
Extracted fractions were immunoblotted for the indicated proteins (left panel). The amount of protein was quantified using image 
J and presented as a percentage of the total (B’). (C) Membrane fractions were prepared as in A and subjected to different chemical 
agents to extract proteins from membranes. Equal amount of proteins were processed for immunoblotting using antibodies against 
VPS13A, EGFR and ATP5A. (D) The amount of protein was quantified as above and presented as a percentage of the total. (E) Sucrose 
gradient fractionation from HeLa cells. HeLa cells were lysed in detergent free buffer and separated in 5-55% sucrose gradients by 
high speed centrifugation. After TCA precipitation, fractions were processed for immunoblotting using antibodies against VPS13A, 
VAP-A, RAB7 and ATP5A. (F) Densitometric quantification of protein band intensities in E was performed using image J and plotted as 
percentage of the total. The plot of VPS13A is highlighted in green.
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Figure 2. Vps13A is localized at mitochondria via its C-terminal.
(A) HEK293T cells were transfected with VPS13A-GFP and the GFP signal was visualized using confocal microscopic examination. White 
arrowheads show reticular structures (A) and pink arrowheads show vesicular structures (A’). Cell borders are marked by white dots, 
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VPS13A localizes to the mitochondrial/ER interface
Furthermore, VSP13A also largely overlapped with the ER marker protein VAP-A (Figure 3A). However, 
not all ER membranes were positive for VPS13A-GFP (Figure 3B and C). To further investigate the co-
localization of VPS13A with the membranes of these organelles, we conducted time-lapse imaging of 
live cells expressing VPS13A-GFP and stained with mitotracker or co-transfected cells with mCherry-
VAP-A. This analysis showed that VPS13A-GFP was closely associated to the ER, and largely followed the ER 
dynamics (Figure 3D and Supplementary Movie 2). VPS13A positive regions of the ER co-localized with the 
mitochondrial marker (Figure 3C).
Given the complete decoration of mitochondria with VPS13A-GFP and its association to the ER, these 
results indicate that VPS13A was enriched at the interface between these two organelles. 
VSP13A directly binds VAP-A through its FFAT motif
We then asked what mediated the VPS13A association to the ER. Several membrane-associated 
proteins bind to the ER resident VAP-A through a 7 amino acids FFAT motif 32–34. Interestingly, VPS13A 
also contains a putative FFAT motif 34, which is located between the amino acids 842-848 (Figure 4A). To 
test whether VPS13A indeed interact with VAP-A, we performed a co-immunoprecipitation experiment 
with endogenous proteins. In line with this hypothesis, VAP-A was enriched in immunoprecipitates of 
endogenous VPS13A (Figure 4B); Similarly, VPS13A was present in the VAP-A immunoprecipitates (Figure 
4B’).
nucleus is marked by red dots. (scale bar=10µm). (B) Single stack image from a time-lapse recording of Hek293T cells expressing 
VPS13A-GFP for 48 hours (Supplementary Movie 1). Mitochondria were labeled using mitotracker orange. B’ Line scan analysis of 
VPS13A-GFP and mitotracker orange (right panel) indicates the peri-mitochondrial localization of VPS13A. Scale bar= 10µm, Insets=1 
µm. (C) Schematic representations of full length VPS13A and N-terminally GFP tagged VPS13A fragments. Numbers denote the first 
and last amino acid positions. (D) GFP-VPS13A constructs represented in C were co-expressed with mCherry-Sec61B in U2OS cells for 
24 hours. Scale bar=25 µm, Insets=5 µm. (E) U2OS cells co-expressing GFP-VPS13A (2615-3174) and BFP-Sec61B for 24 hours were stained 
with mitotracker red. The GFP-VPS13A (2615-3174) outlined the mitotracker signal indicating a mitochondrial outer membrane signal. 
Scale bar=10 µm, insets=2 µm
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Figure 3. Vps13A is localized at ER-mitochondrial interface.
(A) Hek293T cells were co-transfected with VPS13A-Myc and GFP-VAP-A. Cells were stained with anti-myc (red) and DAPI (blue). (B) 
Representative single stack image of Hek293T cells expressing BFP-Sec61B and VPS13A-GFP. Mitochondria labeled using mitotracker 
Red. White arrowheads indicate the enrichment of VPS13A at the ER-mitochondria interface. Pink arrows indicate ER tubule without 
mitochondrial contact and not marked by VPS13A-GFP. Scale bar=2 µm. (C) Representative single stack image of Hek293T cells 
expressing mCherry-VAP-A and VPS13A-GFP. Mitochondria labeled using anti-Tom20 antibody. White arrowheads indicate the 
enrichment of VPS13A at the ER-mitochondria interface. Scale bar=5 µm. (D) Representative time-lapse images of Hek293T cells 
expressing VPS13A-GFP and mCherry-VAP-A for 48 hours (Supplementary Movie 2). White arrowheads show continuous dynamic 
associations of VPS13A-GFP and mCherry VAP-A. Scale bar=10 µm, Insets= 2 µm.
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Figure 4. Direct interaction of VPS13A and VAP-A.
(A) Amino acid sequence alignment of VPS13A-FFAT and 4 other FFAT containing proteins. The FFAT containing region of each 
protein was selected and aligned using ClustalW multiple alignment tool. (B) Endogenous VPS13A was immunoprecipitated from 
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To test whether VSP13A and VAP-A interact via the putative VSP13A FFAT motif, we conducted a set of 
in vitro pull-downs. We generated GST-tagged recombinant VPS13A fragments (Figure 4C) that were 
incubated with bacterially expressed 6x-His tagged VAP-A. We found that all the constructs containing the 
VPS13A FFAT motif were efficiently binding VAP-A (Figure 4D), including the FFAT motif itself (Figure 4D, 
Lane 3). Importantly, the introduction of the D845A point mutation in this motif, which is known to affect 
VAP-A binding in other FFAT-containing proteins 32,35, strongly reduced its association to VAP-A (Figure 
4D, Lane 6). Similar results were obtained when GST-tagged recombinant VPS13A truncated proteins were 
incubated with HeLa cell lysates. Following GSH pull down, endogenous VAP-A from HeLa cells was found 
to be enriched together with GST-VPS13A variants in a FFAT-dependent manner (Supplementary Figure 
4). We concluded that VPS13A interacts with VAP-A via a FFAT domain.
To investigate whether the FFAT motif is required for the localization of VPS13A to the ER, we generated 
a VPS13A FFAT-deletion mutant (VPS13A∆FFAT) tagged with GFP. Analysis of confocal images showed that 
VPS13A∆FFAT localized to mitochondria but no longer to the ER-mitochondria interface indicating that the 
FFAT domain is the main hub for ER targeting of VPS13A (Figure 4E).  The FFAT domain was not sufficient 
for an in vivo association with the ER because FFAT containing truncated VPS13A constructs remained 
cytosolic and did not co-localize to the ER (Figure 2D). 
The assembly of membrane contact sites is regulated by cellular calcium levels 36,37. Calcium levels are 
mainly regulated through the activity of sarcoendoplasmic reticulum calcium ATPase (SERCA), which can 
be pharmacologically inhibited with thapsigargin (TG), leading to an increase in cytosolic calcium. In order 
to understand the effect of cellular calcium on VPS13A-VAP-A interaction, we treated cells with different 
concentrations of TG. Following TG treatment, we found an increased amount of VPS13A bound to VAP-A 
(Figure 4F and G) and such increase was proportional to the concentration of TG applied. The calcium 
mediated VPS13A-VAP-A interaction suggests that VPS13A plays a role in ER-mitochondria contact sites.
In conclusion, our data support a model in which VSP13A can associate simultaneously with mitochondria 
and ER via its C-terminus and FFAT domain, respectively. The FFAT domain is required but not sufficient for 
an ER association, suggesting that a full-length mitochondrial associated VPS13A is required to establish 
the VPS13A-ER connection.  
HeLa cells using an anti-VPS13A antibody. Rabbit IgG was used as a control. (B’) Endogenous VAP-A was immunoprecipitated from 
HeLa cells using an anti-VAP-A antibody. Goat IgG was used as a control. Indicated proteins were detected by immunoblotting. (C) 
Schematic representations of bacterially expressed GST tagged VPS13A fragments used for the in vitro binding assays in D. (D) In Vitro 
binding assay using 6xHis-VAP-A and GST-fusions of VPS13A (depicted in C) expressed in E.Coli. GST-fusion proteins were enriched on 
Sepharose beads and incubated with equal amounts of bacterial lysate containing 6xHis-VAP-A. GST alone used as a control. Samples 
were immunoblotted against VAP-A, GST and N-terminal VPS13A (an antibody that is directed against amino acids 73-174 of VPS13A). 
(E)Representative single stack image of HEK293T cells expressing mCherry-VAP-A (red) and VPS13A-GFP (top) or VPS13A-GFP ∆ FFAT 
(bottom). Scale bar=10 µm. (F) GFP-VAP-A was immunoprecipitated from HeLa cells treated with different concentrations of TG for 
6 hours. DMSO vehicle was used as control. Indicated proteins were detected by immunoblotting. (G) Densitometric quantification 
of protein bands in Figure 4F. The ratio of VPS13A trapped was normalized to the respective amount of GFP-VAP-A. Cells treated with 
DMSO vehicle were used as controls. 
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VPS13A is associated with lipid droplets independent of the FFAT motif 
As shown in Figure 2A’, VPS13A-GFP also brightly decorates vesicular structures in a small percentage of 
the cells, which were not mitochondria (Supplementary movie 1). We noticed that when this localization is 
observed, VPS13A-GFP is absent from the reticular ER-mitochondrial interface (Figure 2A’). Using confocal 
microscopy with lipid droplets (LDs) specific dyes, LipidTox red or Nile-red, we found that these vesicular 
structures were LDs (Figure 5A-B). 
To test this further, cells were cultured under conditions that elicit LD biogenesis. For instance, exogenous 
addition of oleic acid (OA), a fatty acid, known to induce intracellular LD formation 38–40. Cells expressing 
VPS13A-GFP were therefore visualized at different times after OA induction. Before the addition of OA, 
the majority of the VPS13A-GFP signal was present in the reticular pattern reflecting its distribution at the 
mitochondria-ER contact sites (Figure 5C, left panel). After 2h of exposure to OA, VPS13A-GFP was entirely 
re-localized to the FA-BODIPY-positive LDs. Line scan analysis of individual LDs revealed that VPS13A-
GFP uniformly encircled LDs (Figure 5D), suggesting enrichment of VPS13A at the membrane and not at 
the interior of LDs. Live-cell imaging showed that LDs that were VSP13A-GFP negative gradually acquired 
VPS13A from the reticular pool (Figure 5C). This indicated that VPS13A is not always associated with newly 
formed LDs and it can be recruited to already formed LDs.
To corroborate these observations, we next investigated whether endogenous VSP13A was also recruited 
to LDs. We thus analyzed the subcellular distribution of endogenous VPS13A by sucrose gradient 
fractionation of cells grown under normal conditions, starved for serum or exposed to OA for 24 hours 
(Supplementary Figure 5A). Western blot analysis of sucrose gradient fractions revealed that VPS13A 
was mainly enriched in the heavier fractions under starvation and normal growth conditions, and only 
a small portion (~4%) appeared in the fraction corresponding to LDs that floated on top of the sucrose 
gradient, which was identified using the Perilipin2 (PLIN2) as the specific LD marker protein. Part of 
PLIN2 was sequestered in the fractions with high density organelles that contained marker proteins 
such as VAP-A, EGFR and ATP-5A (Figure 6A, B and B’, Supplementary Figure 5 C, D and D’), consistent 
with previous work showing that very minimal amount of LDs are formed under starvation conditions 40. 
Induction of LD formation after incubation of cells with OA for 24 hours leads to a shift in the distribution 
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of endogenous VPS13A towards enrichment at the LD fraction. As expected, PLIN2 was enriched in the 
top fraction consistent with the fact that LDs are formed in response to OA induction (Figure 6C, D and 
D’, Supplementary Figure 5E, F and F’). The distribution of the plasma membrane protein, EGFR and 
the lysosomal protein-LAMP1 was not affected upon OA induction or serum starvation (Figure 6A-D’, 
Supplementary Figure 5 C-F’). In addition, comparison of the amount of VPS13A in the LD fraction showed 
that VPS13A was highly concentrated in the LD fractions of OA fed cells. Addition of 250 µm OA to starved 
cells doubled the amount of VPS13A in the LDs fraction and 500 µm OA increased in the amount of LD 
Figure 5. VPS13A decorates Lipid droplets.
(A) HEK293T cells were transfected with VPS13A-GFP for 24 hours. The vesicular structures colocalized with Lipidtox red that labeled 
LDs. (B) HEK293T cells transfected with VPS13A-GFP were processed as in A. LDs labeled with Nile red. (C) HEK293T cells transfected 
with VPS13A-GFP for 48 hours were pulsed with 1µM BODIPY-FA (red) at 37oC for 30 minutes followed by a chase in medium containing 
500uM OA. Confocal images of the same preparation were taken at different time points. Scale bar=10 µm. (D) Hek293T cells 
transfected with VPS13A-GFP for 48 hours were pulsed with 1µM BODIPY-FA (red) at 37oC for 30 minutes followed by a chase in medium 
containing 500uM OA for 2 hours at 37oC. A Zoom in image of a live cell is shown (top panel). Line profile analysis across the LD 
(bottom panel) showed the enrichment of the VPS13A-GFP signal on the LD membrane. Scale bar=1 µm.
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associated VPS13A by about four fold (Figure 6E and F, Supplementary Figure 5B). Taken together, these 
data confirmed our observation that VPS13A is associated with lipid droplets and this association can be 
enhanced by oleate induced LDs formation.
We then questioned whether the ER localization through VAP-A binding was important for the LD 
localization of VPS13A. To do so, we expressed VPS13A∆FFAT in OA fed cells and showed that it was recruited 
to LDs similar to WT VPS13A (Figure 6G). This indicates that the FFAT motif of VPS13A is not required for its 
recruitment to LDs.  
In conclusion, our results showed that the subcellular localization of VPS13A-GFP is metabolically 
regulated. Surplus amount of cellular lipid leads to LDs biogenesis and directs VPS13A from mitochondria 
to LDs independently from its binding to ER-localized VAP-A.
VPS13A negatively affects lipid droplet size and motility
We further studied the role of VPS13A on LDs by investigating their motility and size under VPS13A 
overexpressing and downregulation conditions. We downregulated VPS13A in U2OS cells and analyzed LD 
number and dynamics. Under normal culturing conditions, VPS13A downregulated cells showed increased 
numbers of bigger LDs and a reduction in small (<5µm) LDs (Figure 7A and B). In addition, fluorescent 
activated cell sorting (FACS) quantification of the total Nile red intensity showed a significantly increased 
intensity in the absence of VPS13A (Figure 7C).  The largest LDs in both mock and VPS13A siRNA treated 
cells were generally immobile. However, smaller and peripheral LDs moved faster in VPS13A depleted cells 
compared to the controls (Figure 7 D and D’).
Live tracking of individual LDs showed that VPS13A-GFP positive LDs slowly and randomly oscillated for a 
longer time. Nonetheless, when these LDS were briefly dissociated from VPS13A-GFP, they directionally 
traveled fast and such mobility was interrupted when VPS13A-GFP was again associated with LDs (Figure 
7E, Supplementary movie 3). Quantitatively, when the mean intensity of VPS13A-GFP at LDs was measured 
in each frame and correlated to the distance it traveled, there was an inversely proportional amount of 
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Figure 6. Endogenous VPS13A is partially recruited to LDs.
(A) FCS starved HeLa cells were processed as described in Supplementary Figure 5A. Fractions with equal amounts of proteins were 
processed for western blotting and detected by immunoblotting against antibodies for VPS13A, LAMP1, EGFR, PLIN2, VAP-A and 
ATP5A. (B) Densitometric quantification of protein band intensities in A was performed using image J and plotted as percentage of 
the total. B’ shows a zoomed in values of the top 3 light sucrose density fractions. (C) FCS starved Hela cells were further incubated 
with 500 µM OA and processed as A. Fractions with equal amounts of proteins were processed for Western blotting and detected by 
immunoblotting against antibodies for VPS13A, LAMP1, EGFR, PLIN2, VAP-A and ATP5A. (D) Densitometric quantification of protein 
band intensities was performed as in B. D’ shows a zoomed in values of the top 3 lowest sucrose density fractions. (E) HeLa cells 
were either grown in complete medium (Ctr), FCS starved (as in A) or further incubated with 250µM or 500µM OA and processed as 
described in A. LDs were isolated from the top fraction. Equal amounts of Proteins were resolved by western blotting and detected by 
immunoblotting against antibodies for VPS13A, LAMP1, EGFR, PLIN2, VAP-A, ATP5A and a-tubulin. (F) Densitometric quantification of 
proteins in LD fraction in E was performed using image J and normalized to inputs of each condition. (G) Representative single stack 
image of HEK293T cells expressing and VPS13A-GFP or VPS13A-GFP ∆ FFAT.  Cells were incubated with 500µM OA  for 3 hours. LDs stained 
with LipidTox red. Scale bar=10 µm
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VPS13A-GFP signal to the speed of  LDs (Figure 7F). 
In summary, the presence of VPS13A on LDs negatively influence their motility and when LDs temporarily 
escape from VPS13A, they showed faster directional mobility. In the absence of VPS13A, increased numbers 
and larger LDs are present, strongly indicating a role of VPS13A in LD homeostasis. 
Lipid droplets accumulate in glia cells of Drosophila Vps13 mutants
Given the influential role of VPS13A on LDs in cell culture, we investigated whether the previously 
established Drosophila vps13-/- model for ChAc 22 exhibits abnormal LD characteristics in brain tissue. 
Drosophila Vps13 is a structural and functional orthologue of human VPS13A 1,22. Homozygous Vps13 
mutants express low levels of a small truncated Vps13 protein and serve as a model for ChAc. Similarly, in 
most of the reported ChAc cases, VPS13A protein cannot be detected in patient material 9. Vps13 mutant 
flies show a decreased life span, normal locomotor function at young age, reduced locomotor function 
and brain vacuoles  upon ageing (17 days and older), indicative for neurodegeneration 22. 
Visualization of lipid droplets using fluorescent markers in combination with light microscopic analysis 
in the Drosophila brain did not show a positive signal, most likely due to limited tissue penetration of 
the dyes. Therefore, we used a large scale electron microscopy approach enabling analysis of entire 
brain areas and to identify possible LDs and affected cells at the ultrastructural level 41 (See materials and 
methods to access data set). As previously reported, in contrast to wild type brains, large vacuoles are 
apparent in neurodegenerative brains of Vps13  homozygous mutants  (Figure 8 A and B). In addition, 
electron microscopic analysis showed an accumulation of LDs throughout the (17 day old) Vps13  mutant 
brain. The central complex (an area with a dense network of neurons and glia,involved in locomotor 
function42) was selected for ultrastructural visualization and quantification of the lipid droplets. No LDs 
were observed in central complex of control brains (Figure 8 C). Only 1 LD was observed in an adjacent 
area (Figure 8E). >30 LDs were observed in the central complex of Vps13 mutants (N=2, complete central 
complexes were analyzed) (Figure 8D) in cells reminiscent of glia 43. LD were also observed in glia in other 
areas of the mutant brain (Figure 8 F-J). Glia are electron dense, non-neuronal cells, surrounding neuronal 
cells in the central nervous system, with a supportive and protecting function 44. The LDs varied in size and 
occasionally occupied the complete cytoplasm of the glia cells. LDs were absent in aged matched wild 
type brains (N=2) (for access to the full data set see materials and methods).
Figure 7. VPS13A negatively regulates LD mobility.
(A) Confocal image of U2OS cells treated with either Mock or VPS13A SiRNA for 72 hours. Cells were fixed and LDs were stained with 
LipidTox red. Nucleus stained with DAPI. Scale bar=10 µm. (B) Size distribution of LDs in A. Single stacks confocal images were captured 
at the middle of cells and LDs were categorized based on their sizes and plotted as percentage of the total. Student’s t-test, *p<0.05, 
** p<0.01, *** P<0.001. (C) U2OS cells were treated with siRNA as in A. cells were stained with Nile red and intensity was measured using 
FACS.  Student’s t-test, *p<0.05, ** p<0.01, *** P<0.001. (D) U2OS cells were treated with siRNA as in A. cells were incubated with Lipidtox 
red 20 minutes before imaging. Time lapse images were taken every second. Two consecutive images were superimposed to see the 
mobility of LDs. D’ Colocalization of LDs in consecutive frames was manually counted and normalized to the total number of LDs and 
plotted as percentage of overlap. (E) Representative montage of HEK293T cells expressing and VPS13A-GFP.  Cells were incubated with 
500µM OA  for 3 hours. LDs stained with LipidTox red. Time lapse images were taken every 600 milliseconds. Scale bar=10 µm. (F) The 
intensity of VPS13A signal on the LD was quantified in every frame and plotted against the speed of the LD.
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Figure 8. LDs accumulate in glia of Drosophila ChAc model 
(A-J) Large scale electron microscopic images. (A) 17 day old Drosophila wild type brain. Insert depicted in A is enlarged in C visualizing 
the central complex of wild type brain. 1 indicates the location of one lipid droplet visualized in E. (B) 17 day old Vps13 mutant brain. 
Insert depicted in B is enlarged in D visualizing the central complex of Vps13 brain. 2,4,5,6 indicate the location of lipid droplets 
visualized in F, H, I and J. (C) Central complex of the wild type brain (link and access codes are provided in materials and methods 
allowing the user to zoom). (D) Central complex of Vps13 mutant brain (link and access codes are provided in materials and methods 
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These data indicate that, comparable to mammalian cells, Vps13 could also play a role to regulate LD 
homeostasis in the Drosophila central nervous system.
DISCUSSION 
We show that VPS13A is at the interface between mitochondria and ER under normal culturing conditions. 
When cellular lipid content is increasing VPS13A dynamically shifts from its mitochondrial-ER interface 
to the membrane of LDs where it influences their mobility (Figure 9). Large LDs are also observed in glia 
cells of an aged Drosophila ChAc model suggesting altered LD homeostasis as a possible explanation for 
neurodegeneration in ChAc.
Our results are partly consistent with previous findings of other VPS13 family members, in addition, unique 
characteristics and functions of VPS13A are being revealed. The peripheral membrane characteristics 
of VPS13A are shared by human VPS13B and C, yeast VPS13p and Drosophila VPS13 8,11,22,45. In addition, 
we identified ER and mitochondrial membranes to be in close association with VPS13A and VPS13A 
directly binds to the ER protein VAP-A through the FFAT motif. VAP-A/B proteins have been extensively 
characterized as a hub when the ER establishes membrane contacts with other organelles including 
endosomes, mitochondria, peroxisomes, plasma membrane (PM) and Golgi 46–55. In combination with 
published data, our results suggest a function for VPS13A in tethering mitochondria and ER and thereby 
building membrane contacts sites facilitating exchange of molecules between these organelles under 
normal culturing conditions. The reported phenotypes of VPS13A depleted cells, impaired autophagic flux 
and mitochondrial clearance 20,21 may result from abnormal mitochondria-ER contact sites. Interestingly, 
in contrast to VPS13A depleted cells, increased mitochondrial clearance is observed in VPS13C depleted 
cells 8.
Under conditions of increased LD formation, an additional organelle is targeted and VPS13A translocates 
from the mitochondrial-ER interface to the surface of LDs. Vps13p in yeast also relocalizes in response to 
a metabolic shift, although to different interfaces;  from vacuole-mitochondria to vacuole-nucleus 16. The 
VPS13A specific association with ER, mitochondria and LDs reveals the presence of a directional pathway 
from the ER-mitochondrial interface to LDs. 
LDs have long been considered as inert lipid inclusions and studies of their biology were constrained 56. 
Evidence is now accumulating that LDs are far from being only fat depots as they are decorated by a large 
number of proteins that regulate their formation, destruction and communication with other organelles 
40,57–63. VPS13A influences the mobility of LDs a feature reminiscent of identified proteins regulating 
dynamics of endosomal vesicles. Endosomal movement is halted when endosomes make contacts with 
the ER 64 and, movement of peroxisomes is increased upon loss of the VAP-ACBD5 tethering complex 48,49. 
allowing the user to zoom in). Insert depicted in D is visualized in G. Central complex area is indicated in red; Blue droplets indicate 
positions of LDs; blue triangles indicate LDs in higher magnifications; N=nucleus; M=mitochondria; red stars indicate electron dense 
cytoplasm characteristic for glia.
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Consistent with this, we show that VPS13A negatively influences LD motility. LDs are more steady when 
they are decorated by VPS13A and move faster in a directional manner when they briefly lose the VPS13A 
signal. 
In addition to a role of VPS13A in mitochondria-ER contact sites, this reflects an additional possible 
function of VPS13A in mediating the formation of contacts between LDs and other organelles. We 
therefore predict that loss of VPS13A affects cellular processes that require mitochondria-ER contact sites 
and exchange of cargo between LDs and other organelles. So far, no other ER-mitochondria interface 
proteins were identified that also influence the dynamics and thereby contact events of LDs with other 
organelles. Interestingly, we found that VPS13A depletion leads to increase number and size of LDs. A 
phenotype that is again opposite to VPS13C loss of function 65, demonstrating that the human VPS13 family 
members possess different functions, which is consistent with the fact that all 4 members are associated 
with unique diseases.
The question remains why loss of VPS13A leads to ChAc, a movement disorder, mostly presenting in the 
third decade of the patient’s life. LD abnormalities are associated with several neurodegenerative diseases 
such as Hereditary spastic paraplegias 66, Huntington’s disease 67, and Parkinson’s disease 68. In ageing 
Vps13 mutant flies, LDs are observed in glia at the age when locomotor function declines and brain 
vacuoles are present.  The role of LD in the adult central nervous system is largely unknown, however, LD 
are transiently formed in Drosophila glia cells surrounding photoreceptors in young flies in response to 
oxidative stress 69 . It is currently not clear whether in the absence of VPS13 LD formation is enhanced or 
degradation/turnover decreased. It may be possible that due to aging, oxidative stress builds up, LDs are 
being formed and accumulate because of a compromised turnover due to decreased contact sites with 
their target organelles. Gradually increasing numbers of large LDs in an aging organism may form physical 
obstructions and thereby hampering the cellular functions of glia and their neighboring neuronal cells. 
Glia cells contribute to increasing numbers of brain diseases 70. Glia cell functions have not been studied 
in ChAc models nor in ChAc patient derived material, leaving this field largely open for future research.
Our study reveals the dynamic localization of VPS13A and highlights a conserved importance of VPS13A 
to regulate LD dynamics and homeostasis in mammalian cells and the central nervous system. VPS13A’s 
movement from a mitochondrial residence to LDs upon metabolic changes reveals an inter-organelle 
directional pathway in which VPS13A plays a central role. 
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Figure 9. Proposed model for VPS13A function.
(A) Under normal growth conditions VPS13A is localized at the ER-mitochondria contact sites where it is anchored to VAP-A through 
its FFAT domain to facilitate cargo exchange between ER and mitochondria. (B) Inhibition of SERCA with thapsigargin increase 
cytosolic calcium and simultaneously increases VPS13A/VAP-A interaction thereby stabilizes ER-mitochondria contacts. (C) Upon 
increased cellular fatty acid intake, VPS13A translocates to LDs where it possibly regulates LD contact sites formation and stabilization 
thereby limiting LD mobility. 
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MATERIALS AND METHODS
Immunoblotting
Cells were homogenized by sonication in 2x laemmli buffer that contains urea (sigma) and DTT (Sigma) 
to a final concentration of 0.8M and 50mM respectively. After the homogenates were boiled at 99 oC 
for 5 minutes, the indicated proteins were resolved with polyacrylamide gel and transferred to PVDF 
membrane using the Trans-Blot Turbo System (Bio-Rad) or overnight wet transfer. Membranes blocked 
in 5% fat free milk for 1 hour at room temperature, rinsed in PBS-Tween 20. Incubations with primary 
antibodies were done overnight at 4 oC followed by incubations with secondary antibodies for 1.5 hours at 
room temperature. The following primary antibodies were used: anti-VPS13A (Sigma,1:1000), anti-VPS13A 
(N-terminal) (Santacruz Biotechnology, 1:500) anti-myc (1:1000), anti-GFP (Clontec 1:1000), anti VAP-A 
(Santacruz Biotechnology, 1:1000), anti-EGFR (Santacruz Biotechnology, 1:1000), anti-α tubulin (Sigma, 
1:5000), anti-GAPDH (Fitzgerald 1:10,000), anti-LAMP1 (abcam, 1:1000), anti ATP5A (abcam, 1:1000), anti-
GST (Santacruz Biotechnology, 1:1000), anti Rab7 (abcam, 1:1000), Membrane was developed using ECL 
reagent (Thermoscientific) and signal was imaged using the ChemiDoc imager (Biorad) , images exported 
as Tiff files and densitometric analysis of band intensities was performed using imge J software. 
Cell culture and transfection
Hela, U2OS and Hek293T cells were cultured in DMEM (Gibco or Sigma) containing 10 % FCS and Penicilin/
streptomycin (Gibco) in 5 % CO2 at 37 OC. Plasmid transfections of Hela and U2OS cells were done using 
polyethylenimine (PEI) transfection reagent. Cells were analysed after 24 or 48 hours of transfection. 
Medium was refreshed 24 hours post transfection. For procedures that require overexpression of full 
length VPS13A-GFP or VPS13A-Myc, HEK293T cells were transfected using Calcium Phosphate precipitation 
method. Cells were analysed 24 or 48 hours after transfection. Medium was refreshed 24 hours after 
transfection
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SiRNA
SiRNA transfection was performed using lipofectamine 2000 (Invitrogen) according to manufacturer’s 
direction. SiRNA transfected cells were analysed 72 hours after transfection. VPS13A SmartPool SiRNA was 
purchased from Dharmacon. Non targeting SirNA pool was used as a control throughout. 
Immunoprecipitation
Hela cells were washed once with ice cold PBS and scrapped in ice cold PBS. After removal of PBS 
following brief centrifugation, cells were resusupended in immunoprecipitation buffer (50mM Tris Hcl, 
150mM NaCl, 1mM EDTA, 1.5mM MgCl2, 10mM KCl, 1% Triton x-100, PH 7.6) supplemented with protease 
inhibitor cocktail (Roche). Cells were snap frozen in liquid nitrogen and passed through 26 gauge 
needle. The homogenate was spun down at 10000 xg for 10 mins, the supernatant was recovered and 
subjected to overnight immunoprecipitation using indicated antibodies or control IgG of the same host. 
Immunoprecipitates were enriched on agarose beads (santacruz) at 4oC for 1.5 hrs. Agarose beads were 
gently washed with buffer and resuspended in 2x laemmli buffer containing DTT and urea and processed 
for immunoblotting as described above. Co-immunoprecipitation using GFP-Trap beads (Chromo Tek) 
was done according to manufactures directions. 
Digitonin extraction
Digitonin extraction of cytosolic proteins was performed according to 31. Briefly, HEK293T cells were 
cultured in 5cm dishes. When about 70% confluent, cells were collected by trypsinization, washed with 
ice cold PBS and resusupended in 5ml of digitonin buffer (150mM Nacl, 50mM HEPES PH=7.4, 25ug/ml 
digitonin, protease inhibitor coctail). After rolling the suspension for 10 minutes at 4oC, the tube was 
centrifuged at 2000xG for 5 minutes. The supernatant was collected as cytosolic fraction. The pellet was 
washed once with cold PBS and resuspended in 5 ml of NP-40 buffer (150mM NaCl, 50mM HEPES PH=7.4, 
1% NP-40, protease inhibitor coctail). After rolling the suspension for 30 minutes at 4 degrees, the tube 
was centrifuged at 7000xG for 5 minutes. The supernatant was collected as membrane fraction. Both 
the cytosolic and membrane fractions underwent TCA precipitation and equal amounts of proteins were 
processed for immunoblotting as described above.
Immunofluorescence
Fixed cells 
Cells grown on poly L-lysine coated coverglasses were transfected with the respective SiRNA. 72hours 
after SiRNA, cells were fixed in 4% paraformaldehyde. For LipidTox staining, cells were quenched for 10 
minutes in 50mM NH4Cl in PBS and permeabilized for 5 minutess with 0.1% Triton x-100 in PBS followed by 
incubation with LipidTox dye (1:200). Cells were mounted using citifluor mounting medium (Agar Scientific) 
and imaged immediately. Confocal images of cells were collected either using Leica sp8 confocal laser 
scanning microscope fitted with 63x oil immersion objective or DeltaVison confocal microscope (applied 
precision) fitted with 60x or 100x oil immersion objective. Images from the Delta vision were deconvolved 
by the SoftwoRx software (Applied Precision). Mitotracker (Invitrogen) was added for 20 minutes in serum 
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free medium at a concentration of 100nM (for live) and 200nM (for fixed) cells. 
Live cells
For Live imaging procedures, cells were seeded in 35mm glass bottom dishes coated with poly-d-lysine 
(Mat Tek). Live cell recordings were made using a DeltaVision confocal microscope. Prior to imaging, 
the cage was allowed to reach 37oC and cells were supplemented with 5% CO
2
 throughout the entire 
recording. Images were deconvolved by the softworx software and stored as movies.
Ultrastructural analysis
Fixation, embedding of Drosophila brain tissue and processing for ultrastructural analysis of large images 
was performed as previously described 71. 
For full access of the wildtype brain




fill in pixel size 1 upon request
For full access of the Vps13 mutant brain




fill in pixel size 1 upon request
In vitro Protein-protein interaction
GST-tagged protein coding plasmids were transformed in E.coli BL21 and bacteria was grown overnight. 
Protein expression was induced using IPTG (final concentration of 1mM). Cells were pelleted by 
centrifugation and broken down by sonification in lysis buffer (50mM Tris HCl, PH+7.5, 150mM NaCl, 5% 
glycerol, 0.1% Triton x-100 and 1mM PSMF ) supplemented with protease inhibitor cocktail (Roche). Debris 
was removed by centrifugation and the clean supernatant was mixed with glutathione beads. For protein-
protein interaction assays, a bacterial lysate that contains His-VAP-A or HeLa cell lysate was added to the 
GST-VPS13A enriched beads and incubated at 4 oC. 
Cytosol and Membrane fractionation 
Around 4-5, 90% confluent, T75 flasks of HeLa cells were resuspended in 1ml homogenization buffer HB 
(50mM Tris HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, Protease inhibitor). The cell suspension was lysate 
through 2 freeze-thaw cycles and 20 strokes using a 27g needle. The nuclei and intact cells were pelleted 
by centrifugation 5 min at 800 g, and the resulting postnuclear supernatant (PNS) was applied to 
ultracentrifugation at 100,000 g, 4 C, for 1 h using a TLA 100.3 rotor to generate the cytosol (C) and the 
membrane fraction (M). Membrane fraction was washed in 1ml of HB and centrifuged 1h at 100000g. 
Laemmli sample buffer was added to the cytosol and membrane fractions, samples were quantified and 
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20µg of proteins of each sample were loaded on SDS-gel and processed for Western blot analysis. 
Membrane extraction
The membrane fractions were resuspended in HB (control), 1 M KCl, 0.2 M sodium carbonate (pH 11), 
or 6 M urea for 45 min shaking on ice, and then centrifuged at 4°C, 100,000 g for 1 h obtaining  soluble 
(supernatant) and insoluble (pellet) fractions. Laemmli sample buffer was added to the insoluble and 
soluble fractions, samples were quantified and 20µg of proteins of each sample were loaded on SDS-gel 
and processed for Western blot analysis. 
Subcellular fractionation 
For subcellular fractionation around 5-6, 90% confluent, T75 flasks of HeLa cells were resuspended in 
1 ml of homogenization buffer HB (50mM Tris HCl pH 7,5, 150mM NaCl, 1mM EDTA, Protease inhibitor, 
0.25 M sucrose). The cell suspension was homogenized as previously described to obtain PNS. The 
PNS was then loaded onto a 10ml continuous sucrose gradient containing 5%- 55% (w/v) in HB, and the 
gradient was spun at 4°C at 274 000 g for 4 h using a swinging bucket SW41 rotor in a Sorvall Discovery 
90se. Gradient fractions of 0.5 ml were collected from top to bottom. The proteins in each fraction were 
concentrated using TCA precipitation and resuspendend in 75-100 µl of sample buffer. All the procedures 
were performed on ice. Equal volume of each fraction was loaded on SDS-gel and processed for Western 
blot analysis. 
LD fractionation
Hela cells were collected by trypsinization and washed once with PBS. After the PBS was removed following 
brief centrifugation, cell pellets were resusupended in detergent free homogenizing buffer (50mM Tris 
Hcl, 150mM NaCl, 1mM EDTA, 1.5mM MgCl2, 10mM KCl, PH 7.6) supplemented with protease inhibitor 
cocktail. Cells were snap frozen in liquid nitrogen and passed through 26 gauge needle. Nucleus and 
unbroken cells were removed by spinning down at 1600 xg for 5 mins. The supernatant was recovered 
and mixed with equal volumes of 0.25M sucrose in homogenizing buffer. After saving an input, the sample 
was loaded on top of a discontinuous sucrose gradient prepared by layering 1 ml of 30%, 20%, 10% and 5 
% sucrose in SW55 ultracentrifuge tube. The gradient was centrifuged for 3hours at 40000 RPM using an 
ultracentrifuge (Beckman coulter). Tubes were carefully removed and 8 fractions of 600ul were collected 
from top to bottom. 600ul of the top fraction containing LDs was collected using a 20ul pipette with 
a tip cut off. The refractive index of each fraction was measured and correlated to the linearity of the 
sucrose concentration throughout the tube. The bottom part containing the pellet was resusupended 
with buffer to a final volume of 600ul and was neither included in the refractive index measurement nor in 
the quantification of protein distribution among gradients. Proteins from each fraction were precipitated 
using the trichloroacetic acid precipitation method. Equal amounts of proteins were processed for 
immunoblotting as described above. The amount of protein in each fraction was calculated as a ratio 
of the densitometric signal in each fraction to the sum of the total protein in fractions 1-8 (Protein per 
fraction = densitometeric signal of a fraction/ sum of total densitometeric signal (1-8) x 100%.
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Plasmids and constructs
Human VPS13A-GFP and VPS13A-Myc plasmids were kind gifts from A. Velayos-Baeza. To generate GFP-
VPS13A (2-854), GFP-VPS13A (835-1700), GFP-VPS13A (855-1700), GFP-VPS13A (2003-2606) and GFP-VPS13A 
(2615-3174), the fragments were amplified by PCR from the full length VPS13A and inserted in to pEGFP-C1 
(Clontech) via BamHI and Xhol restriction sites. To generate GST-VPS13A (4-113), GST-VPS13A (114-855), 
GST-VPS13A (2-835), GST-VPS13A (2-854), GST-VPS13A (835-1600), GST-VPS13A (855-1600), GST-VPS13A 
(2003-2606) and GST-VPS13A (2615-3174), the fragments were amplified by PCR from the full length VPS13A 
and inserted into PGEX5x2 (GE Healthcare) with Sall and Notl restriction sites. To produce GST-VPS13A (2-
854/ D845A), a mutagenesis was performed on GST-VPS13A (2-854), with the QuickChange Site Directed 
mutagenesis kit (Agilent) according to the protocol. To construct GST FFAT, oligonucleotides encoding 
the FFAT domain in human VPS13A (AA 842-848) and flanked with SalI and 3’ NotI were synthesized, 
annealed and inserted into pGex5x2 via SalI and NotI. To construct His-VAP-A, Human VAP-A was 
amplified with PCR from HEK293 cDNA and inserted into pET28a (EMD Biosciences) with NdeI and BamHI 
restriction sites. To construct GFP-VAP-A, VAP-A was amplified with PCR from His-VAP-A and inserted into 
pEGFP-C1 (Clontech) with EcoRI and BamHI. To construct mCherry-VAP-A, tubulin in pcDNA3.1 mCherry 
tubulin (kind gift from B. Giepmans) was replaced by VAP-A by using PCR and subcloned with BspEI and 
XhoI. BFP-Sec61B (Addgene plasmid #49154 ) and mCherry-Sec61B (Addgene plasmid #49155) were kind 
gifts from Gia Voeltz 72. GFP-Rab5 Q79L (Addgene plasmid #28046) and GFP-Rab7 Q67L (Addgene plasmid 
#28049 ) were kind gifts from Qing Zhong 73. Lamp1-mGFP (Addgene plasmid # 34831) was a kind gift from 
Esteban Dell’Angelica 74. mCherry Fyco1 was a kind gift from Harald Stenmark 64
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SUPPLEMENTARY FIGURES
Supplementary Figure 1. VPS13A does not colocalize with endocytic compartment.
(A) 48 hours after transfection with either VPS13A-myc or VPS13A-GFP, HEK293T cells were processed for immunoblotting using 
antibodies against VPS13A, a-tubulin, Myc and GFP.. GFP transfected or non-transfected (NT) cells were used as controls. Note the 
enrichment of VPS13A in both VPS13A-myc or VPS13A-GFP lanes. (B) Densitometric quantification of protein bands in A. The ratio of 
VPS13A to -tubulin was normalized to NT cells. (C) HEK293T cells were co-transfected with VPS13A-Myc and GFP-Rab5 Q79L. Cells 
were stained with anti-myc (red) and DAPI (blue). (D) HEK293T cells were co-transfected with VPS13A-Myc and GFP-Rab7 Q67L. Cells 
were stained with anti-myc (red) and DAPI (blue). (E) HEK293T cells were co-transfected with VPS13A-Myc and LAMP1-GFP. Cells were 
stained with anti-myc (red) and DAPI (blue). (F) HEK293T cells were co-transfected with VPS13A-Myc and mCherry FYCO1. Cells were 
stained with anti-myc (green) and DAPI (blue).
495 VPS13A is associated with multiple organelles
Supplementary Figure 2. VPS13A truncated constructs.
GFP-VPS13A constructs represented in Figure 2C and used in figure 2D, 2E and Supplementary figure 3 were overexpressed in Hek293T 
cells for 24 hours. Western blot samples were resolved on SDS PAGE and probed for an anti-GFP antibody. GFP alone was used as a 
control. The stain free scan of the gel is shown as a loading control.
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Supplementary Figure 3. The C-terminal VPS13A localizes to mitochondria in different cell lines. 
(A) GFP-VPS13A (2003-2606) and GFP-VPS13A (2615-3174) constructs were Co-expressed with mCherry Sec61B in HEK293T. Scale bar=25 
µm. (B) GFP-VPS13A (2003-2606) and GFP-VPS13A (2615-3174) constructs were Co-expressed with mCherry Sec61B in HeLa cells. Scale 
bar=25 µm. (C) GFP-VPS13A (2003-2606) and GFP-VPS13A (2615-3174) constructs were Co-expressed with mCherry Sec61B in U2OS. 
Scale bar=25 µm.
497 VPS13A is associated with multiple organelles
Supplementary Figure 4. VPS13A interacts with VAP-A. 
GST-fusion proteins of VPS13A fragments expressed in E.Coli were enriched on Sepharose beads and incubated with equal amounts of 
HeLa cell lysate. GST alone used as a control. Samples were immunoblotted against VAP-A, GST and N-terminal VPS13A (an antibody 
that is directed against amino acids 73-174 of VPS13A). 
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Supplementary Figure 5. Endogenous VPS13A is recruited to LDs up on OA induction.
(A) Workflow of LD isolation and sucrose gradient fractionation. FCS starved Hela cells and Hela cells further incubated for 24 hours 
with 500uM OA in FCS free medium were lysed and fractionated in 5-30% sucrose density gradients. Proteins in fractions were 
concentrated by TCA precipitation and subsequently separated by SDS- PAGE. (B) The ratio of VPS13A in the LD fraction of Figure 
6A and and 6C. The amount of VPS13A before OA (Stv) is was set to 1. (C) HeLa cells grown in complete medium were fractionated 
on sucrose gradient and processed as described in Supplementary Figure 5A. Equal amounts of proteins were resolved by western 
blotting and detected by immunoblotting against antibodies for VPS13A, LAMP1, EGFR, PLIN2, VAP-A and ATP5A. (D) Densitometric 
quantification of protein band intensities in B was performed using image J and plotted as percentage of the total. D’ shows a zoomed 
in values of the top 3 fractions. (E) FCS starved Hela cells were further incubated with 250uM OA and processed as described in B. Equal 
amounts of proteins were resolved by western blotting and detected by immunoblotting against antibodies for VPS13A, LAMP1, EGFR, 
PLIN2, VAP-A and ATP5A. (F) Densitometric quantification of protein band intensities in E was performed using image J and plotted as 
percentage of the total. F’ shows a zoomed in values of the top 3 fractions.
Supplementary Figure 6. Original blots
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Supplementary Figure 6. Original blots
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SUMMARIZING DISCUSSION
Over 30 years ago, yeast Vps13 was discovered as one of the proteins required for carboxypeptidase Y 
(CPY) sorting1–3. The presence of four human Vps13 orthologues and their associations with the onsets 
of clinically distinct neurological and developmental disorders4–7 calls for the demand to mechanistically 
study each VPS13 protein in multicellular organisms. The challenge has been in defining the localization 
and functional contributions of each VPS13 family member in molecular pathways.
Vps13 is a very large protein and in fact the fifth largest protein in the yeast proteome8. Extraordinarily 
large proteins often incur technical challenges. It is extremely difficult to clone full-length cDNAs 
encoding such proteins and equally cumbersome to overexpress them. In this thesis, using Drosophila 
and mammalian cell models, we identify the localization, interaction and an essential role of VPS13A in 
proteotoxic handling, synaptic structure, organelle contacts and  lipid droplet (LD) dynamics.  
Localization and membrane association of VPS13A
Mutations in VPS13A are associated with Chorea-Acanthocytosis (ChAc)4. One of the long standing 
questions in the ChAc field was to pinpoint the subcellular localization of VPS13A. In this thesis, we provide 
for the first time, evidence that VPS13A is a peripheral membrane protein, predominantly associated with 
multiple intracellular organelles. In Drosophila, Vps13 is enriched in endosomal fractions (Chapter 2), 
while in cultured human cells, VPS13A is mainly localized at the ER-mitochondria junctions under normal 
culturing conditions and is dynamically associated with LDs depending on the cellular lipid content 
(Chapter 4). 
Multiple lines of evidence established that VPS13 family members are membrane bound proteins3,6,9. 
The exact topological arrangement of each protein on intracellular organelles was not demonstrated 
in these manuscripts. Nonetheless, in several organisms, chemical extraction or enzymatic cleavage 
methods were used to examine membrane binding properties of VPS13 proteins3,5,6. VPS13B and VPS13C 
are peripheral membrane proteins that are bound to the Golgi and mitochondrial outer membrane 
respectively6,9. Similarly, yeast Vps13 is extracted into the aqueous medium after Triton X-114 treatment 
while integral membrane proteins do remain in the detergent phase3. In chapter 2, we demonstrated that 
Drosophila Vps13 is enriched in membrane fractions and co-immunoprecipitates with Rab7 containing 
organelles. Furthermore, Vps13 dissociates from membrane compartments upon chemical treatments 
that also extract the peripheral membrane protein ATP5A10. 
Similar to Drosophila VPS13A, human VPS13A also has characteristics of a peripheral membrane protein 
(chapter 4). VPS13A primarily targets mitochondria through its C-terminal. Although it remains to be 
investigated whether VPS13A directly binds to  mitochondrial outer membrane lipids or is peripherally 
bound to integral membrane proteins, we do show that VPS13A directly binds to the ER protein VAP-A 
through the FFAT motif (chapter 4). 
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VPS13A in Autophagy: structural similarities between VPS13A and ATG2
The coordinated balance between protein translation, assembly and clearance maintains the steadiness 
of the proteome and governs cellular anatomy and physiology. Failure in proteostasis is a hallmark of 
many neurodegenerative and age relates disorders11. Eukaryotic cells use two major catabolic processes 
(autophagy and proteosomal degradation) as housekeeping mechanisms to maintain proper balance 
of their proteome12. Macroautophagy (shortly autophagy) is a bulk degradative system where cytosolic 
contents such as proteins, organelles or microorganisms are engulfed by isolation membranes to form 
autophagosomes. Autophagosomes subsequently fuse with lysosomes and their contents are digested 
by hydrolytic enzymes13. A number of AuTophaGy related (ATG) proteins have been identified which 
regulate the autophagic process14–16. ATG2 is one of the ATG proteins essential for autophagy and in its 
absence autophagosome membrane closure is incomplete17. 
The Chorein, ATG-C and APT1 domains of Vps13 show high homology with the N-terminal, C- terminal and 
APT1 domains of Atg2 respectively18–20. Both Vps13 and Atg2 bind to PtdIns3p via their APT domains20,21. In 
cultured cells, both proteins are recruited to LDs upon oleic acid treatment17,19,22(Chapter 4). In addition, 
downregulation of either Atg2 or Vps13 in different organisms impairs autophagy, suggesting that both 
proteins are required for an efficient autophagic flux 15,17,23,24. It is however not clear whether any of the 
VPS13A domains are directly involved in autophagic function of mammalian cells. Interestingly, in Chapter 
2, we demonstrated that Drosophila Vps13 co-fractionates with endosomal markers and specifically 
immunoisolates with Rab7 positive organelles, suggesting a localization to the degradative compartment10. 
Vps13 also regulates sorting and endosomal recycling of cargo proteins25. Indeed, in chapter 2 we revealed 
that ubiquitinated and autophagic cargo proteins are accumulated in a Vps13 deficient Drosophila model, 
a phenotype that is partly rescued by human VPS13A. Consistently, in ChAc patient cells, autophagic cargo 
and lysosomal proteins are accumulated and this is associated with delayed mitochondrial clearance24. 
The structure of Vps13 was revealed only recently. Negative stain electron microscopy (EM) combined 
with single particle analysis showed that Vps13 has a distinctive structure with an extended rod in the 
middle flanked by a hook at one end and a loop at the opposite end26. The flexibility of the middle rod 
renders the hook and loop to be either arranged in the same or opposite directions. The frequency of 
these two forms and how the particular conformation is associated with the abundancy of certain lipids 
and interacting proteins remains to be determined. Interestingly, there is a structural similarity between 
Vps13 and Atg2. Both VPS13 and ATG2 have a hook and a loop at opposite sides of the protein26,27  (Figure 1A 
and B). Insertion of a detectable protein label at different sites of ATG2 followed by single particle analysis 
revealed that both C- and N-terminal ends are located to the same tip of the folded protein and both 
ends are located at the  opposite site of the loop27. It is therefore reasonable to assume that the C-terminal 
and Chorein domains are tangled together to form the hook end of VPS13A. 
Notably, in addition to the previously defined domains, our bioinformatics search using the  PRABI 
coiled-coils prediction programme, revealed that VPS13A contains a coiled-coil region close to the 
Chorein domain (Figure 1C and D). Coiled-coil domains are key zippers for protein dimerization28,29. These 
observations highlight that dimerization may determine the steric arrangement of VPS13A. It remains to 
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be shown whether the domains described above are required for localization, stability or proper function 
of VPS13A in biological systems.  Moreover, it would be exciting to investigate whether malfunctioning of 
specific domains contribute to ChAc.
Figure 1. The structure of Vps13. 
(A) Vps13 typically has a loop on one end and a hook on the opposite.( Adapted from26) (B) Left panel - ATG2A-WIPI4 complex. Both 
the N- and C-terminal ends of ATG2A are located at the tip of the rod part. Right panel - ATG2 alone. Adapted from27 (C) Coiled-coil 
prediction of full length VPS13A. Predictions were done using the PRABI programme. https://npsa-prabi.ibcp.fr/cgi-bin/npsa_automat.
pl?page=npsa_lupas.html. Regions of high probability score are enlarged in D. 
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Actin polymerization defects in ChAc models
Actin is one of the most abundant intracellular proteins in mammalian cells30. It is found in either a 
soluble monomeric form (G-actin) or as polymerized actin (F-actin). Actin cytoskeleton defects have 
been implicated in many neurodegenerative disorders including ChAc31–34. ChAc patients‘ cells, VPS13A 
depleted cultured cells and Vps13 mutant yeast cells show an apparent reduction in expression of actin 
and impaired actin polymerization32,35,36 which might contribute to the observed abnormal mechanical 
properties and impaired lamellipodia formation 37. 
Dynamic assembly or disassembly of actin regulates many cellular processes including intracellular 
transport, organelle fission, spine morphogenesis, and synaptic plasticity31,33,34,38,39. Interestingly, 
abnormal outgrowth of NMJ is apparent in Vps13 mutant larvae (Chapter 3). In addition, actin forms 
immunocomplexes with both mammalian VPS13A and yeast Vps1320,40. Along these lines, VPS13A silencing 
turns down PI3K activity and its downstream targets Rac1 and PAK1; all of which inherently regulate actin 
polymerization32. 
Actin polymerization is also regulated by phosphoinositides41–43. For instance, actin comets are formed 
in vitro on vesicles that are enriched with both PI(4,5)P2  and Ptdns3p44. Increased synthesis of PI(4,5)P2 
from Ptdns4p triggers actin comets. Nonetheless, production of PI(4,5)P2 without Ptdns4p consumption 
induces membrane ruffles indicating that co-regulation of various phosphoinositides determines the fate 
of actin organization45. Vps13 directly binds to a range of phosphoinositides26. Furthermore, the amount 
and distribution of Ptdns4p is significantly impaired in VPS13A depleted PC12 cells, which also show 
neurite degeneration after NGF stimulation46, this suggests a link between impaired function of human 
VPS13A and actin organization defects. It is therefore justified to infer that VPS13 could modulate actin 
cytoskeleton maintenance possibly by regulating phosphoinositide metabolism.
VPS13A in membrane contact sites
A typical feature of eukaryotic cells is the presence of intracellular compartments known as organelles; 
each with their own unique lipid and protein composition. Although membrane separation ensures 
segregation of macromolecules, organelles must communicate in harmony in order for cells to efficiently 
function as a coherent unit47–49. Organelles are not autonomously self-sufficient; their homeostasis is 
often dependent on proper exchange of information with neighbor-organelles. For proper organelle 
homeostasis, the right amount of molecules such as proteins and lipids that are distantly synthesized 
need to be delivered to the target destination at the right time48.  
Transport of lipids and proteins is accomplished through vesicular or non-vesicular transport pathways. 
Vesicular transport is an ATP dependent process that often involves fusion of organelles. Non-vesicular 
transport on the contrary is an energy independent, short-range and rapid transport that occurs at 
specialized bridges (10-30nm) between closely apposed membranes known as membrane contact sites 
(MCS)48,50,51.
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In the 1950’s EM analyses led to the identification MCSs: where people observed very close orientations 
of highly specialized ER tubules with mitochondria and the plasma membrane (PM)52,53. Although the 
closeness of these membranes was apparently more than what could have happened by chance, it was 
not clear why membranes of two separate organelles come in contact. It later became obvious that 
phospholipids can be transferred between mitochondria and microsomes without membrane fusion, 
suggesting the presence of a separate pathway enabling macromolecule transport other than the 
vesicular transport system54,55. However, it is only recently that the molecular function and architecture of 
MCSs start to emerge56.
One of the most remarkable factors that mediate contact sites with ER is the ability of some, if not all, 
contact site proteins to bind to VAP, a conserved ER resident transmembrane protein57. VAP-A/B proteins 
have been extensively characterized as MCS hubs when the ER establishes membrane contacts with 
other organelles including endosomes, mitochondria, peroxisomes, the plasma membrane (PM) and the 
Golgi28,58–66.
VAP binding proteins contain a specialized stretch of amino acid sequences (FFAT) that enables them to 
bind to the MSP (major sperm protein) domain of VAP and a second domain that guides their localization 
to the other organelle58,60,61,65. The consensus FFAT motif has a sequence of EFFDAxE, where x can be any 
amino acid. Amino acid substitutions in the FFAT motif are highly tolerated and proteins that directly bind 
VAP do not always possess a canonical FFAT sequence. For example, protrudin binds to VAP-A via its FFAT 
motif (EFKDAIE). Where the natural substitution F>K is tolerated, VAP-A binding of protrudin is inhibited 
upon D>A substitution67.
Bioinformatics data mining for proteins harboring FFAT motif pools a number of human proteins including 
VPS13A and VPS13C68. Nonetheless, it is not clear whether all proteins identified are able to bind VAP. Our 
immunoprecipitation experiments revealed that endogenous VPS13A and VAP-A are pooled in the same 
complex. Using bacterially expressed VPS13A fragments, it was also shown that VPS13A binds to VAP-A 
through the FFAT motif (EFFDAPC) and, D>A substitution in the VPS13A-FFAT sequence partially inhibits 
VAP-A binding. Live tracking of VPS13A with simultaneous visualization of the ER or mitochondria showed 
that VPS13A is associated with both organelles. Almost every mitochondrion is decorated with VPS13A 
and is in close association with the ER. Importantly, deleting FFAT from VPS13A restricts its localization 
only to the mitochondria suggesting that FFAT is an important signal for ER localization of VPS13A 
(Chapter 4). Altogether, these results uncover the previously unknown localization of VPS13A and its main 
determinants of organelle recruitment. 
Membrane contact sites bridge exchange of molecules such as Ca2+ and lipids69.  The largest cellular 
store of Ca2+ is present in the ER at a millimolar range while cytosolic Ca2+ is only in a nanomolar range. 
This gradient is maintained through coordinated regulation of ER membrane proteins such as Sarco-
Endoplasmic Reticulum Ca2+-ATPase SERCA and Inositol-1,4,5-triphosphate Receptors (IP3Rs). The former 
pumps calcium from cytosol to ER while the latter releases calcium from ER to the cytosol69,70. 
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ER Ca2+ store depletion activates the interaction of stromal interacting molecule (STIM) and Orai Ca2+ 
entry channels to allow Ca2+ influx in to the cell. Experimentally, increased cytosolic Ca2+ can be achieved 
by inhibiting SERCA. Inhibition of SERCA activates Store-Operated Ca2+ Entry (SOCE) leading to a massive 
influx of Ca2+ from extracellular medium to the cytosol71. The expression of STIM1 and Orai1, and the 
overall rate of SOCE is diminished in ChAc patient cells72 suggesting that calcium homeostasis might be 
mis-regulated in ChAc. Inhibition of SERCA increases the intensity of MCSs between ER and a number 
of other organelles including PM and mitochondria73,74. In cultured cells, inhibition of SERCA increases 
the interaction between VPS13A and VAP-A suggesting an enhanced formation of VPS13A mediated ER-
mitochondria contact sites (Chapter 4). However, the exact role of VPS13A in calcium homeostasis is still 
unclear. 
Synthetic biology screen in yeast uncovered a protein complex bridging ER and mitochondria; hence the 
name ER-Mitochondrial Encounter Structure (ERMES) was coined.  Four core subunits make up ERMES: 
Mmm1/ Mdm12 /Mdm34 and Mdm10. Mdm10 and Mdm34 are mitochondrial proteins that are in complex 
with Mmm1 (an integral ER protein) and a soluble Mdm1275. Disruption of ERMES does not completely 
abolish lipid transport suggesting the presence of an independent compensatory mechanism76. 
Identification of vCLAMP (vacuole and mitochondria patch) unveiled the importance of organelle cross-
talk as ERMES mutants are synthetically lethal when combined with loss of vCLAMP. Growth defects of 
ERMES mutants are rescued by the overexpression of vCLAMP. Moreover, the expansion of vCLAMP in 
ERMES mutants further explains the presence of a co-regulated compensatory mechanism between 
MCSs to maintain organelle health77,78. 
It is still a subject of debate whether ERMES regulates direct lipid transport between ER and 
mitochondria75,79. In a recent in vitro study, ERMES mutants expressing a Vps13 dominant mutant show 
defective phospholipid transfer from ER to mitochondria but not from mitochondria to ER80. On the other 
hand, Vps13 depleted cells do not have detectable defects in total phospholipid levels or synthesis of lipids 
that demand ER-mitochondria contact sites8 suggesting that Vps13 may not directly transfer lipids. 
Like Vps13, overexpression of Mdm10 complementing protein (Mcp1) and Mcp2 rescue ERMES 
mutant-associated growth defects. Both Mcp1 and Mcp2 are mitochondrial proteins and loss of Mcp1 
is synthetically lethal when combined with ERMES mutants81. An interesting crosstalk between Mcp1 
and Vps13 to overcome ERMES mutant growth defects was reported: Mcp1 is mandatory for the Vps13 
dominant mutant mediated rescue of ERMES growth defects8. Simultaneously, Mcp1 requires Vps13 
to function normally 82. Indeed, Mcp1 and Vps13 interact with each other and overexpression of Mcp1 
sequesters Vps13 from vesicles to mitochondria82.
Loss of ERMES induces an iron deficiency response and leads to iron accumulation83, a phenotype that is 
suppressed by the Vps13 dominant mutation. Mcp1 has predicted heme-binding domains and disruption 
of these domains fail to restore ERMES defects82. However future experiments are required to decipher 
whether VPS13A deficiency causes iron imbalance as a result of MCS malformation and whether such 
failure contributes to the onset or progression of ChAc. Because the mammalian counterpart of Mcp1 
is not known and VPS13A is localized to the mitochondria without overexpression of another protein, 
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an interesting question remains what determines the localization of human VPS13A to mitochondria. A 
conceivable hypothesis would be: VPS13A, via one or several of its C-terminal domains, interacts either 
with mitochondrial membrane protein/s or with outer membrane lipids and thereby exposes its FFAT 
to the cytosol to make membrane bridges between ER and mitochondria. It however remains to be 
investigated whether VPS13A and other mammalian VPS13 family proteins recapitulate the reported yeast 
Vps13 functions at MCSs. 
VPS13A in LD homeostasis
In eukaryotes, lipid storage and consumption are in a tightly regulated balance in order to adapt to 
changes of energy demand and supply84–86. Cellular energy is stored in LDs as a form of triacylglycerols and 
sterol esters85,87. The exact mechanism underlying LD biogenesis is unclear. However, there is a growing 
number of evidence which supports the idea that lipid droplets arise from the ER. The favorable model 
that depicts LD formation is that neutral lipids accumulate at specific microdomains of the ER between 
the two leaflets of the bilayer such that a bulge of phospholipid monolayer that contains a neutral lipid 
core is formed and later bud from the ER86,88,89.
LDs are not only enriched in lipids. A large number of proteins also target LDs to regulate their synthesis 
and determine their fate86,88,90–96. Protein targeting to LDs is often mediated through the presence of 
either amphipathic α-helices or hydrophobic hairpins (AH)92,97,98. Amphipathic helices serve as membrane 
curvature sensors99. Interestingly, both human VPS13A and yeast Vps13 contain putative amphipathic 
α-helices100. Human VPS13A is predicted to contain a single amphipathic α-helix at position 2959-2982 
while yeast Vps13 contains two putative amphipathic α-helices at positions 2889-2911 and 2933-2954 
(Figure 2)100.
Figure 2. Amphipathic helices of VPS13. 
Previously predicted100 amphipathic α-helices of both human VPS13A and yeast Vps13 were analyzed using the heliquest programme. 
(http://heliquest.ipmc.cnrs.fr/)  Hydrophobic amino acids are yellow shaded. Numbers in brackets denote amino acid positions of 
each stretch 
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Proteomic analysis of LDs from Drosophila embryos identified several proteins including Vps1394. 
Additionally, Vps13 is localized to LDs of seipin mutant cells but not control cells101. Seipin is an ER 
membrane protein that is required for proper formation and maturation of LDs, maintenance of ER-LD 
contact sites, cargo delivery and modulation of intracellular calcium homeostasis90,91,95. Thus, the focal 
accumulation of Vps13 in LDs of seipin mutants dictates a possible function of Vps13 in LD homeostasis. It 
is however not clear whether Vps13 is localized in response to a compensatory mechanism of defective 
LD homeostasis or because of the destabilized ER-LD contact in seipin mutants.
Data presented in this thesis illustrates that human VPS13A is recruited to LDs when cellular lipid is surplus. 
Fatty acid supplementation and subsequent localization of VPS13A to LDS is not accompanied with an 
elevated VPS13A translation but with a reduction of VPS13A signal from mitochondria (Chapter 4). We also 
show that VPS13A negatively influences LD motility. LDs are slow when they are associated with VPS13A 
and move faster directionally when they are dissociated from VPS13A. Moreover, VPS13A deficient flies 
and human cells show impaired LD homeostasis. Together, these results reflect a conserved function of 
VPS13A in LD dynamics perhaps by establishing MCSs between LDs and neighboring organelles. 
MCSs govern organelle mobility: such that endosomes and peroxisomes are mobile upon loss of tethering 
complex60,61,102. We therefore predict that loss of MCSs in VPS13A depleted cells might abrogate lipolysis 
and/or FA transfer to other organelles and consequently account for an increase in LD size number. Of 
note, increased LD size creates a surface tension that is unfavorable for lipases103,104. 
Upon nutrient deprivation, cells undergo lipolysis to liberate fatty acids (FAs) from lipid droplets. The 
released FAs are immediately taken up by the mitochondria for ATP production through the process 
of β-oxidation105. Under such conditions, mitochondria reside in close proximity with LDs likely for the 
efficient transfer of FAs105,106. In addition, nutrient starvation promotes mitochondrial elongation and 
fragmented mitochondria are evident in cells that do lack mitochondrial fusion proteins such as mfn1 and 
Opa163,105. Such mutants do have increased number and size of LDs likely because they reroute free fatty 
acids back to LDs for esterification and storage105. It is therefore tempting to investigate the role of VPS13A 
in mitochondrial respiration and morphological organization.
Impaired LD homeostasis in neurodegenerative diseases
In the nervous system, lipids play vital roles, such as myelination, synaptic integrity and global 
metabolism107–109. Mutations of lipid binding proteins and changes in brain lipid profiles have been 
implicated in neurodegeneration110–113. However until recently, the role of LDs in the nervous system has 
not been appreciated. LD accumulation has been documented in mouse models as well as in lymphoblasts 
and brain slices of Huntington’s disease patients114.  The role of LDs in the Drosophila brain have been 
comprehensively investigated115–118 and, in chapter 4, we demonstrated that LDs accumulate in glia cells of 
Vps13 deficient flies.
There appears to be a cross talk between neuronal and glial cells to properly handle lipotoxic insults. For 
example, glial LDs sequester toxic lipid species and thereby safeguard neuronal precursors from oxidative 
114 CHAPTER 5
attacks118. Glia specific down regulation of mitochondrial complex I leads to lipid droplet accumulation 
and neurodegeneration117. In mutants with neuronal mitochondrial dysfunction, LDs accumulate in glia 
cells non-cell-autonomously. Neuronal mitochondrial dysfunction liberates reactive oxygen species 
(ROS) that triggers the activation of sterol regulatory element binding protein (SREBP) and c-Jun-N-
terminal-kinase (JNK) pathways. Activation of these pathways enhances excessive formation of glial LDs 
and subsequently promotes neurodegeneration115. The exact mechanism of such non-cell autonomous 
regulation is not completely understood, but a recent study has been illuminating.  Inter-cellular shuttling 
of lactate from glia to neurons fuels neuronal lipid formation during ROS production. Hereto, specific 
fatty acid transporter channel lipids to glial cells116.
CONCLUDING REMARDKS AND PERSPECTIVES
Data presented in this thesis not only defines a previously unidentified localization and interaction of 
VPS13A but also highlights a conserved importance of VPS13A to regulate LD dynamics in both mammalian 
cell lines and Drosophila ChAc model. We believe that the function of VPS13A is not limited to what is 
reported in this thesis. However, considering the key evidences and available tools, we believe that the 
molecular pathways governing ChAc are within reach. Because LD accumulation and impaired protein 
homeostasis were documented in our ChAc models, it would be interesting in the future to link VPS13A’s 
role in autophagy and LD homeostasis. The question of how impaired LD dynamics contributes to ChAc 
remains to be solved. Therefore, future study involving the function of VPS13A in lipid biosynthesis and 
transport, membrane contact integrity and ER-LD-mitochondria interplay would give us insights to 
better understand the pathophysiological processes of ChAc and to further identify druggable targets. 
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Chorea-Acanthocytose (ChAc) is een zeldzame autosomaal recessieve neurodegeneratieve aandoening, 
die voornamelijk gekenmerkt wordt door verslechtering van locomotor en cognitieve vermogens 
naarmate de patiënten ouder worden. Ook hebben de patiënten onwillekeurige bewegingen van hun 
ledematen en last van abnormale spierspanningen van de mond en de tong. Bovendien wordt de ziekte 
gekenmerkt door abnormale rode bloedcellen met doornachtige uitsteeksels, ook wel acanthocyten 
genoemd. ChAc wordt veroorzaakt door mutaties in het VPS13A gen. Bij de meeste patiënten resulteren 
deze mutaties in een sterk verminderde hoeveelheid van het eiwit of leidt dit zelfs tot een totale 
afwezigheid van het eiwit VPS13A. Hoe het kan dat de afwezigheid van dit eiwit leidt tot abnormaliteiten 
in het brein en in de bloedcellen is grotendeels onbekend.
Gist was het eerste organisme waarin de mogelijke functies van het VPS13 eiwit zijn bestudeerd. Studies 
in dit organisme laten zien dat gistcellen waarin het VPS13 eiwit ontbreekt, problemen hebben met het 
intracellulaire transport van bepaalde enzymen van het trans-Golgi netwerk (TGN) naar de vaculole toe. 
Vervolgstudies in gist lieten zien dat het eiwit in veel cellulaire processen een rol speelt, zoals het maken 
van de prosporen, endosomale sorting, het vormen van membraan contact sites en VPS13 speelt ook 
een rol bij het fuseren van membraan-structuren. Er is veel Informatie betreffende VPS13 verkregen uit 
giststudies maar ook uit studies met andere organismen, maar, wat VPS13A nu precies doet in menselijke 
cellen is grotendeels onbekend. Dit komt mede omdat mensen vier verschillende VPS13 eiwitten 
hebben (namelijk VPS13A, B, C en D) en gist heeft maar één VPS13 eiwit. Mutaties in de vier verschillende 
menselijke VPS13 genen, leiden tot vier zeer verschillende ziektebeelden. Mutaties in VPS13A, B, C en D zijn 
respectievelijk geassocieerd met ChAc, Cohen’s syndroom, de ziekte van Parkinson en met verhoogde 
sterfte vanwege een septische shock. Om dit te begrijpen is het belangrijk dat er experimentele modellen 
gemaakt worden waarin de functies van deze vier individuele VPS13 eiwitten afzonderlijk bestudeerd 
kunnen worden. Het doel van dit proefschrift was om er achter te komen op welke plaats in een cel 
het VPS13A zich bevindt en wat de moleculaire functies zijn van VPS13A in gezond weefsel en wat de 
consequenties zijn voor een diermodel en een humane cel als het VPS13A afwezig is.
Onderzoek naar ChAc wordt ernstig beperkt omdat er geen goede moleculaire en celbiologische 
middelen zijn en omdat er geen goede modelsystemen zijn die gebruikt kunnen worden om het VPS13A 
te bestuderen. In het tweede hoofdstuk van dit proefschrift hebben we een fruitvliegmodel voor VPS13A 
gemaakt, gevalideerd en gekarakteriseerd. We hebben laten zien dat in vliegen, het Vps13 eiwit vooral zit 
in het centrale zenuw stelsel. Vliegen die geen Vps13 hebben, laten afbraak zien van het zenuwstelsel en 
ze gaan veel eerder dood dan de controle vliegen. Dit zijn eigenschappen die lijken op wat er in patiënten 
gebeurt. Verder worden er in Vps13 mutante vliegen meer eiwitten gevonden die geubiquitineerd zijn. 
In de fruitvlieg is het Vps13 eiwit verrijkt aanwezig in endosomale structuren van de cel en met name 
specifiek aanwezig in Rab7 positieve cel organellen. Dit suggereert dat in vliegen het Vps13 geassocieerd 
is met late endosomen of met lysosomen. Dit suggereert ook dat de neurodegeneratie die we zien in 
vliegen deels komt door een verslechterde transport en/of afbraak van eiwitten. Dit is een kenmerk die 
veel wordt aangetroffen in menselijke neurodegeneratieve ziekten. Dit zou dus ook een rol kunnen 
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spelen in de ziekte ChAc.
Wat ook vaak wordt gezien in patiënten met een neurodegeneratieve ziekte, is dat er geen goede 
regulatie is tussen zenuwen en spieren en de spieren worden hierdoor niet goed aangestuurd. Om dit 
te bestuderen hebben we in vliegen gekeken naar structuren die hierbij een rol spelen zoals de spieren 
zelf en de neuromusculaire junctions (NMJ).  NMJ’s zijn synapsen en spelen een belangrijke rol tussen 
de informatie overdracht tussen zenuwen en spieren en NMJ’s zijn al goed onderzocht in vliegen. Het 
larvale stadium is zeer geschikt om de NMJ’s te bestuderen. Ons onderzoek liet zien dat Vps13 mutanten 
sneller kruipen in vergelijking met controle larven, dit laat zien dat deze larven hypermobiel zijn. 
Deze hypermobiliteit is niet geassocieerd met een grotere spiermassa. Een analyse van de NMJ’s liet 
vervolgens zien dat deze meer synaptische boutons bevatten vergeleken met controle larven.  Ook zijn 
de synaptische boutons kleiner en laten ze meer glutamaat receptoren zien. Samenvattend laten we in 
hoofdstuk 3 zien dat de synapsen er abnormaal uitzien en dit is geassocieerd met een verhoogde kruip 
activiteit van de larvae.
In hoofdstuk  vier laten we zien waar in menselijke cellen het VPS13A eiwit zit en hebben we gevonden 
dat het op verschillende celorganellen zit. Om dit aan te tonen hebben we veel verschillende technieken 
gebruikt. Ook is het humane VPS13A net als in vliegen een perifeer membraan eiwit.
Alles samenvattend laten we in dit proefschrift zien dat de functie van VPS13 sterk geconserveerd is in de 
loop van de evolutie en dat het een belangrijke rol speelt in de communicatie tussen celorganellen en in 
het behoud van de eiwithomeostase. Echter het exacte mechanisme hoe VPS13A dat doet en hoe verlies 
van het eiwit leidt tot een hersenziekte èn abnormale rode bloedcellen blijft onopgelost. Desalniettemin 
zijn het Drosophila model en de door ons ontwikkelde biochemische en moleculaire hulpmiddelen 
heel handig om te gebruiken bij verdere studies om de functie van VPS13A te doorgronden en om zo 
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